Jens Overgaard

Professor

Jens Overgaard

Professor

  • Institut for Klinisk Medicin - Eksperimentel Klinisk Onkologi
Postaddresse:
Palle Juul-Jensens Boulevard 35
8200
Aarhus N
Danmark

E-mail: jens@oncology.au.dk

Fødselsår

1945

Uddannelser

2013x
2012x
2011x
2010x
2009x
2008x

Akademiske grader

2013x
2012x
2011x

Forskningsområder

Clinical and Experimental Radiation Oncology
Head and neck, ocular and breast cancer

Nuværende ansættelse

?Professor, Department of Experimental Clinical Oncology, Aarhus University Hospital, Danmark
?Direktør, CIRRO - The Lundbeckfoundation Center for Interventional Research in Radiation Oncology, Danmark
?Direktør, DAFKO, Danish Graduate School for Clinical Oncology, Denmark
?Coordinator of the Danish Head and Neck Cancer Group (DAHANCA), Danmark
?Formand, Kræftens Bekæmpelse; Scientific Komité, Danmark

Tidligere ansættelser

2013x
2012x
2011x
2010x
2009x
2008x

Publikationer og præsentationer

Publikationer: >600, Peer-reviewed artikler: >450, Bogkapitler: ?, H-index: 74, Citationer: >25.000, Patenter: 6, Præsentationer ved videnskabelige møder (oral): >800.

Participated in >300 scientific meetings, frequently as chairman or invited speaker (more than 300 invited presentations).

Udvalgs- og bestyrelsesposter

x

Organisering af kliniske forsøg

Titel + personrolle = Investigator

Vejledning

Projects in oncology and radiotherapy
This includes 15 completed and 2 ongoing Dr. Med. Sci. theses
43 completed and 18 ongoing PhD theses and 14 completed Master projects

Bedømmelser

x

Priser og udmærkelser

More than 30 international and national Scientific awards, including Breur Gold Medal Award, ESTRO (1989)
Regaud Medal (2002)
The pezcoller Foundation-ECCO Award (2011)
Honorary member of 7 international societies
Fellow of the Royal College of Radiologists, London (1994)
Honorary Fellow of the American College of Radiology (2005)
Founding member of the European Academy of Cancer Sciences (2009)

RESEARCH GRANTS :
Since 1980's continously grants from Danish Cancer Society
Danish Medical Research Council, The Danish Council for Strategic Research, The Lundbeck
Foundation

Større forskningsbevillinger

x

Ekstern bedømmer for fonde

x

Organisering af møder

x

Involvering i videnskabelige tidsskrifter

Editor-in-chief Radiotherapy and Oncology
Editor Acta Oncologgica
Founding Editor-in-chief Int. J. Hyperthermia
Editorial board member of 17 international scientific journals

Medlemsskaber

x

Publikationer

Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224)

Saksø, M., Mortensen, L. S., Primdahl, H., Johansen, J., Kallehauge, J., Hansen, C. R. & Overgaard, J., okt. 2020, I : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 151, s. 126-133

Patterns in detection of recurrence among patients treated for breast cancer

Saltbaek, L., Horsboel, T. A., Offersen, B. V., Andersson, M., Friberg, A. S., Skriver, S. K., Bidstrup, P. E., Overgaard, J., Johansen, C. & Dalton, S. O., 6 aug. 2020, I : Breast Cancer Research and Treatment. 9 s.

A population-based study of the incidence and mortality of second primary cancers in Danish patients with retinoblastoma, 1943-2013

Gregersen, P. A., Halgreen, M., Urbak, S. F., Funding, M., Dalton, S., Overgaard, J. & Alsner, J., aug. 2020, (Accepteret/In press) I : JAMA Network Open.

Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy

Zschaeck, S., Löck, S., Hofheinz, F., Zips, D., Saksø Mortensen, L., Zöphel, K., Troost, E. G. C., Boeke, S., Saksø, M., Mönnich, D., Seidlitz, A., Johansen, J., Skripcak, T., Gregoire, V., Overgaard, J., Baumann, M. & Krause, M., aug. 2020, I : Radiotherapy and Oncology. 149, s. 189-196 8 s.

Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smoking

Lilja-Fischer, J. K., Eriksen, J. G., Georgsen, J. B., Vo, T. T., Larsen, S. R., Cheng, J., Busch-Sørensen, M., Aurora-Garg, D., Steiniche, T. & Overgaard, J., jun. 2020, I : Acta Oncologica. 59, 6, s. 666-672

Prognostic value of a 15-gene hypoxia classifier in oropharyngeal cancer treated with accelerated chemoradiotherapy

Deschuymer, S., Sørensen, B. S., Dok, R., Laenen, A., Hauben, E., Overgaard, J. & Nuyts, S., jun. 2020, I : Strahlentherapie und Onkologie. 196, 6, s. 552-560 9 s.

Four decades with ESTRO

Overgaard, J. & Baumann, M., jan. 2020, I : Radiotherapy and Oncology. 142, s. 1-5 5 s.

DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, larynx and oral cavity

Saksø, M., Jensen, K., Andersen, M., Hansen, C. R., Eriksen, J. G. & Overgaard, J., 2020, I : Radiotherapy and Oncology. 148, s. 65-72 8 s.

DAHANCA 33: functional image-guided dose-escalated radiotherapy to patients with hypoxic squamous cell carcinoma of the head and neck (NCT02976051)

Saksø, M., Primdahl, H., Johansen, J., Nowicka-Matus, K., Overgaard, J. & DAHANCA, 2020, I : Acta Oncologica. 59, 2, s. 208-211 4 s.

Long-term follow-up on shoulder and arm morbidity in patients treated for early breast cancer

Hauerslev, K. R., Madsen, A. H., Overgaard, J., Damsgaard, T. E. & Christiansen, P., 2020, I : Acta Oncologica. 59, 7, s. 851-858 8 s.

Radiotherapy & Oncology during the COVID-19 pandemic

Baumann, M., Overgaard, J. & Bacchus, C., 2020, I : Radiotherapy and Oncology. 146, s. 221-222 2 s.

The Danish head and neck cancer group (DAHANCA) 2020 radiotherapy guidelines

Jensen, K., Friborg, J., Hansen, C. R., Samsøe, E., Johansen, J., Andersen, M., Smulders, B., Andersen, E., Nielsen, M. S., Eriksen, J. G., Petersen, J. B. B., Elstrøm, U. V., Holm, A. I., Farhadi, M., Morthorst, M. H., Skyt, P. S., Overgaard, J. & Grau, C., 2020, I : Radiotherapy & Oncology. 151, s. 149-151 3 s.

DAHANCA 9–a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC)

Evensen, J. F., Sand Hansen, H., Overgaard, M., Johansen, J., Andersen, L. J. & Overgaard, J., 3 okt. 2019, I : Acta Oncologica. 58, 10, s. 1502-1505 4 s.

BIGART 2019 - adapting to the future

Overgaard, J., Muren, L. P., Høyer, M. & Grau, C., okt. 2019, I : Acta Oncologica. 58, 10, s. 1323-1327 5 s.

Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts

Lilja-Fischer, J. K., Ulhøi, B. P., Alsner, J., Stougaard, M., Thomsen, M. S., Busk, M., Lassen, P., Steiniche, T., Nielsen, V. E. & Overgaard, J., okt. 2019, I : Acta Oncologica. 58, 10, s. 1489-1494 6 s.

NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy

Hansen, C. R., Friborg, J., Jensen, K., Samsøe, E., Johnsen, L., Zukauskaite, R., Grau, C., Maare, C., Johansen, J., Primdahl, H., Bratland, Kristensen, C. A., Andersen, M., Eriksen, J. G. & Overgaard, J., okt. 2019, I : Acta Oncologica. 58, 10, s. 1410-1415 6 s.

Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy

Löck, S., Linge, A., Seidlitz, A., Bandurska-Luque, A., Nowak, A., Gudziol, V., Buchholz, F., Aust, D. E., Baretton, G. B., Zöphel, K., Steinbach, J., Kotzerke, J., Overgaard, J., Zips, D., Krause, M., Baumann, M. & Troost, E. G. C., jun. 2019, I : Radiotherapy and Oncology. 135, s. 43-50 8 s.

Analysis of EORTC-1219-DAHANCA-29 trial plans demonstrates the potential of knowledge-based planning to provide patient-specific treatment plan quality assurance

Tol, J. P., Dahele, M., Gregoire, V., Overgaard, J., Slotman, B. J. & Verbakel, W. F. A. R., jan. 2019, I : Radiotherapy & Oncology. 130, s. 75-81 7 s.

A prospective, multicenter DAHANCA study of hyperfractionated, accelerated radiotherapy for head and neck squamous cell carcinoma

Saksø, M., Andersen, E., Bentzen, J., Andersen, M., Johansen, J., Primdahl, H., Overgaard, J. & Eriksen, J. G., 2019, I : Acta Oncologica. 58, 10, s. 1495-1501 7 s.

Distinguishing recurrence and new primary tumor as well as the origin of neck metastases in head and neck cancer clinical trials by targeted DNA sequencing

Lilja-Fischer, J. K., Saksø, M., Stougaard, M., Steiniche, T. & Overgaard, J., 2019, I : Acta Oncologica. 58, 10, s. 1506-1508 3 s.

Dual-tracer PET of viable tumor volume and hypoxia for identification of necrosis-containing radio-resistant Sub-volumes

Busk, M., Horsman, M. R., Overgaard, J. & Jakobsen, S., 2019, I : Acta Oncologica. 58, 10, s. 1476-1482 7 s.

Publishing your trial protocols with Acta Oncologica; your contribution to scientific transparency

Nilbert, M. & Overgaard, J., 2019, I : Acta Oncologica. 58, 6, s. 821 1 s.

Subglottic squamous cell carcinoma in Denmark 1971–2015–a national population-based cohort study from DAHANCA, the Danish Head and Neck Cancer group

Hill-Madsen, L., Kristensen, C. A., Andersen, E., Johansen, J., Andersen, L. J., Primdahl, H., Overgaard, J. & Lyhne, N. M., 2019, I : Acta Oncologica. 58, 10, s. 1509-1513 5 s.

IMRT – Biomarkers for dose escalation, dose de-escalation and personalized medicine in radiotherapy for head and neck cancer

Andreassen, C. N., Eriksen, J. G., Jensen, K., Hansen, C. R., Sørensen, B. S., Lassen, P., Alsner, J., Schack, L. M. H., Overgaard, J. & Grau, C., 1 nov. 2018, I : Oral Oncology. 86, s. 91-99 9 s.

Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial

Brøndum, L., Alsner, J., Sørensen, B. S., Maare, C., Johansen, J., Primdahl, H., Evensen, J. F., Kristensen, C. A., Andersen, L. J., Overgaard, J. & Eriksen, J. G., sep. 2018, I : Acta Oncologica. 57, 9, s. 1159-1164 6 s.

DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group

Overgaard, J., Hoff, C. M., Hansen, H. S., Specht, L., Overgaard, M., Lassen, P., Andersen, E., Johansen, J., Andersen, L. J., Evensen, J. F., Alsner, J. & Grau, C., 1 apr. 2018, I : Radiotherapy & Oncology. 127, 1, s. 12-19 8 s.

The management and survival outcomes of nasopharyngeal cancer in the Nordic countries

Mäkitie, A., Ruuskanen, M., Bentzen, J., Brun, E., Gebre-Medhin, M., Friesland, S., Marsk, E., Hammarstedt-Nordenvall, L., Gille, E., Reizenstein, J., Adell, G., Farnebo, L., Rzepecki, J., Haugen, H., Söderström, K., Zackrisson, B., Bergström, S., Lödén, B., Cederblad, L., Laurell, G., Smeland, E., Folkvard Evensen, J., Lund, J. Å., Tøndel, H., Karlsdottir, Å., Jóhannsson, J., Johansen, J., Kristensen, C. A., Jensen, K., Andersen, L. J., Koivunen, P., Korpela, M., Voutilainen, L., Wigren, T., Minn, H., Joensuu, H., Overgaard, J. & Saarilahti, K., apr. 2018, I : Acta Oncologica. 57, 4, s. 557-560 4 s.

Is DBCG abreast of new developments?

Offersen, B. V., Ejlertsen, B., Balslev, E., Flyger, H., Gerdes, A-M., Hansen, M. K., Hølmich, L. R., Jensen, M-B., Kristensen, B., Laenkholm, A-V., Mouridsen, H. T., Nielsen, M. H., Overgaard, J., Tuxen, M., Vejborg, I. & Christiansen, P., 18 jan. 2018, I : Acta Oncologica. 57, 1, s. 1-2 2 s.

Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration

Ejlertsen, B., Offersen, B. V., Overgaard, J., Christiansen, P., Jensen, M-B., Kroman, N., Knoop, A. S. & Mouridsen, H., jan. 2018, I : Acta Oncologica. 57, 1, s. 3-12 10 s.

Influence of intra-tumoral heterogeneity on the evaluation of BCL2, E-cadherin, EGFR, EMMPRIN, and Ki-67 expression in tissue microarrays from breast cancer

Tramm, T., Kyndi, M., Sørensen, F. B., Overgaard, J. & Alsner, J., jan. 2018, I : Acta Oncologica. 57, 1, s. 102-106 5 s.

Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy - results from two independent randomized trials

Laurberg, T., Tramm, T., Nielsen, T., Alsner, J., Nord, S., Myhre, S., Sørlie, T., Leung, S., Fan, C., Perou, C., Gelmon, K., Overgaard, J., Voduc, D., Prat, A. & Cheang, M. C. U., jan. 2018, I : Acta Oncologica. 57, 1, s. 38-43 6 s.

Local recurrences after curative IMRT for HNSCC

Zukauskaite, R., Hansen, C. R., Grau, C., Samsøe, E., Johansen, J., Petersen, J. B. B., Andersen, E., Brink, C., Overgaard, J. & Eriksen, J. G., jan. 2018, I : Radiotherapy & Oncology. 126, 1, s. 48-55 8 s.

Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project

Lassen, P., Lacas, B., Pignon, J-P., Trotti, A., Zackrisson, B., Zhang, Q., Overgaard, J., Blanchard, P. & MARCH Collaborative Group, jan. 2018, I : Radiotherapy & Oncology. 126, 1, s. 107-115 9 s.

APD-Containing Cyclolipodepsipeptides Target Mitochondrial Function in Hypoxic Cancer Cells

Jacobsen, K. M., Villadsen, N. L., Tørring, T., Nielsen, C. B., Salomón, T., Nielsen, M. M., Tsakos, M., Sibbersen, C., Scavenius, C., Nielsen, R., Christensen, E. I., Guerra, P. F., Bross, P., Pedersen, J. S., Enghild, J. J., Johannsen, M., Frøkiær, J., Overgaard, J., Horsman, M. R., Busk, M. & Poulsen, T. B., 2018, I : Cell Chemical Biology. 25, 11, s. 1337-1349 13 s.

Analysis of CT-verified loco-regional recurrences after definitive IMRT for HNSCC using site of origin estimation methods

Zukauskaite, R., Hansen, C. R., Brink, C., Johansen, J., Asmussen, J. T., Grau, C., Overgaard, J. & Eriksen, J. G., nov. 2017, I : Acta Oncologica. 56, 11, s. 1554-1561 8 s.

Differential gene expression in primary fibroblasts induced by proton and cobalt-60 beam irradiation

Nielsen, S., Bassler, N., Grzanka, L., Swakon, J., Olko, P., Andreassen, C. N., Overgaard, J., Alsner, J. & Sørensen, B. S., nov. 2017, I : Acta Oncologica. 56, 11, s. 1406-1412 7 s.

Intrinsic subtype characterization of local recurrences and new contralateral primary tumors in patients with low risk breast cancer. Influence of age and primary surgery

Laurberg, T. & Overgaard, J., nov. 2017, I : Acta Oncologica. 56, 11, s. 1644-1647 4 s.

Relative biological effectiveness (RBE) and distal edge effects of proton radiation on early damage in vivo

Sørensen, B. S., Bassler, N., Nielsen, S., Horsman, M. R., Grzanka, L., Spejlborg, H., Swakoń, J., Olko, P. & Overgaard, J., nov. 2017, I : Acta Oncologica. 56, 11, s. 1387-1391 5 s.

Rethink radiotherapy - BIGART 2017

Grau, C., Høyer, M., Poulsen, P. R., Muren, L. P., Korreman, S. S., Tanderup, K., Lindegaard, J. C., Alsner, J. & Overgaard, J., nov. 2017, I : Acta Oncologica. 56, 11, s. 1341-1352 12 s.

Validation of genetic predictors of late radiation-induced morbidity in prostate cancer patients

Schack, L. M. H., Petersen, S. E., Nielsen, S., Lundby, L., Høyer, M., Bentzen, L., Overgaard, J., Andreassen, C. N. & Alsner, J., nov. 2017, I : Acta Oncologica. 56, 11, s. 1514-1521 8 s.

Role of radiotherapy fractionation in head and neck cancers (MARCH): An updated meta-analysis

Lacas, B., Bourhis, J., Overgaard, J., Zhang, Q., Grégoire, V., Nankivell, M., Zackrisson, B., Szutkowski, Z., Suwiński, R., Poulsen, M., O'Sullivan, B., Corvò, R., Laskar, S. G., Fallai, C., Yamazaki, H., Dobrowsky, W., Cho, K. H., Garden, A. S., Langendijk, J. A., Viegas, C. M. P., Hay, J., Lotayef, M., Parmar, M. K. B., Aupérin, A., van Herpen, C., Maingon, P., Trotti, A. M., Grau, C., Pignon, J. P. & Blanchard, P., sep. 2017, I : Lancet Oncology. 18, 9, s. 1221-1237 17 s.

Placebo-controlled phase II study of vitamin K3 cream for the treatment of cetuximab-induced rash

Eriksen, J. G., Kaalund, I., Clemmensen, O., Overgaard, J. & Pfeiffer, P., jul. 2017, I : Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 25, 7, s. 2179-2185 7 s.

Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV/p16 negative squamous cell carcinoma of the head and neck: Results of the benchmark case procedure

Christiaens, M., Collette, S., Overgaard, J., Gregoire, V., Kazmierska, J., Castadot, P., Giralt, J., Grant, W., Tomsej, M., Bar-Deroma, R., Monti, A. F., Hurkmans, C. W. & Weber, D. C., jun. 2017, I : Radiotherapy & Oncology. 123, 3, s. 424-430 7 s.

FDG-PET reproducibility in tumor-bearing mice: comparing a traditional SUV approach with a tumor-to-brain tissue ratio approach

Busk, M., Munk, O. L., Jakobsen, S., Frøkiær, J., Overgaard, J. & Horsman, M. R., maj 2017, I : Acta oncologica (Stockholm, Sweden). 56, 5, s. 706-712

Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome

Aure, M. R., Vitelli, V., Jernström, S., Kumar, S., Krohn, M., Due, E. U., Haukaas, T. H., Leivonen, S-K., Vollan, H. K. M., Lüders, T., Rødland, E., Vaske, C. J., Zhao, W., Møller, E. K., Nord, S., Giskeødegård, G. F., Bathen, T. F., Caldas, C., Tramm, T., Alsner, J., Overgaard, J., Geisler, J., Bukholm, I. R. K., Naume, B., Schlichting, E., Sauer, T., Mills, G. B., Kåresen, R., Mælandsmo, G. M., Lingjærde, O. C., Frigessi, A., Kristensen, V. N., Børresen-Dale, A-L., Sahlberg, K. K. & OSBREAC, 29 mar. 2017, I : Breast Cancer Research. 19, 1, 18 s., 44.

Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients

Brøndum, L., Eriksen, J. G., Singers Sørensen, B., Mortensen, L. S., Toustrup, K., Overgaard, J. & Alsner, J., feb. 2017, I : Clinical and Translational Radiation Oncology. 2, s. 46-52 7 s.

Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients

Laurberg, T., Alsner, J., Tramm, T., Jensen, V., Lyngholm, C. D., Christiansen, P. M. & Overgaard, J., jan. 2017, I : Acta Oncologica. 56, 1, s. 59-67 9 s.

HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)

Linge, A., Lohaus, F., Löck, S., Nowak, A., Gudziol, V., Valentini, C., von Neubeck, C., Jütz, M., Tinhofer, I., Budach, V., Sak, A., Stuschke, M., Balermpas, P., Rödel, C., Grosu, A-L., Abdollahi, A., Debus, J., Ganswindt, U., Belka, C., Pigorsch, S., Combs, S. E., Mönnich, D., Zips, D., Buchholz, F., Aust, D. E., Baretton, G. B., Thames, H. D., Dubrovska, A., Alsner, J., Overgaard, J., Krause, M., Baumann, M. & DKTK-ROG, dec. 2016, I : Radiotherapy & Oncology. 121, 3, s. 364-373 10 s.

Radiation-induced morbidity evaluated by high-frequency ultrasound

Schack, L. M. H., Alsner, J., Overgaard, J., Andreassen, C. N. & Offersen, B. V., dec. 2016, I : Acta Oncologica. 55, 12, s. 1498-1500 3 s.

Risk of second non-breast cancer among patients treated with and without postoperative radiotherapy for primary breast cancer: A systematic review and meta-analysis of population-based studies including 522,739 patients

Grantzau, T. & Overgaard, J., dec. 2016, I : Radiotherapy & Oncology. 121, 3, s. 402-413 12 s.

So long, Farewell, Au revoir, Auf Weidersehen

Overgaard, J., dec. 2016, I : Radiotherapy & Oncology. 121, 3, s. 345-347 3 s.

The relative biological effectiveness of antiprotons

Holzscheiter, M. H., Alsner, J., Bassler, N., Boll, R., Caccia, M., Knudsen, H., Maggiore, C., Petersen, J. B., Sellner, S., Strasse, T., Sørensen, B. S. & Overgaard, J., dec. 2016, I : Radiotherapy & Oncology. 121, 3, s. 453-458 6 s.

A prognostic profile of hypoxia-induced genes for localised high-grade soft tissue sarcoma

Aggerholm-Pedersen, N., Sørensen, B. S., Overgaard, J., Toustrup, K., Bærentzen, S., Nielsen, O. S., Maretty-Kongstad, K., Nordsmark, M., Alsner, J. & Safwat, A., 25 okt. 2016, I : B J C. 115, 9, s. 1096-1104 9 s.

The Danish Head and Neck Cancer database

Overgaard, J., Jovanovic, A., Godballe, C. & Grau Eriksen, J., 25 okt. 2016, I : Clinical Epidemiology. 8, s. 491-496 6 s.

An evaluation of multiplex bead-based analysis of cytokines and soluble proteins in archived lithium heparin plasma, EDTA plasma and serum samples

Brøndum, L., Sørensen, B. S., Eriksen, J. G., Mortensen, L. S., Lønbro, S., Overgaard, J. & Alsner, J., 26 sep. 2016, I : Scandinavian Journal of Clinical & Laboratory Investigation. 76, 8, s. 601-611 11 s.

The impact of hypoxia and its modification of the outcome of radiotherapy

Horsman, M. R. & Overgaard, J., 16 aug. 2016, I : Journal of Radiation Research. 57, 1, s. 90-98 9 s.

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients

Andreassen, C. N., Rosenstein, B. S., Kerns, S. L., Ostrer, H., De Ruysscher, D., Cesaretti, J. A., Barnett, G. C., Dunning, A. M., Dorling, L., West, C. M. L., Burnet, N. G., Elliott, R., Coles, C., Hall, E., Fachal, L., Vega, A., Gómez-Caamaño, A., Talbot, C. J., Symonds, R. P., De Ruyck, K., Thierens, H., Ost, P., Chang-Claude, J., Seibold, P., Popanda, O., Overgaard, M., Dearnaley, D., Sydes, M. R., Azria, D., Koch, C. A., Parliament, M., Blackshaw, M., Sia, M., Fuentes-Raspall, M. J., Ramon Y Cajal, T., Barnadas, A., Vesprini, D., Gutiérrez-Enríquez, S., Mollà, M., Díez, O., Yarnold, J. R., Overgaard, J., Bentzen, S. M., Alsner, J. & International Radiogenomics Consortium (RgC), 18 jul. 2016, I : Radiotherapy & Oncology.

Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients

Laurberg, T., Lyngholm, C. D., Christiansen, P., Alsner, J. & Overgaard, J., 8 jun. 2016, I : Radiotherapy & Oncology. 120, 1, s. 98-106 9 s.

Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG

Linge, A., Löck, S., Gudziol, V., Nowak, A., Lohaus, F., von Neubeck, C., Jütz, M., Abdollahi, A., Debus, J., Tinhofer, I., Budach, V., Sak, A., Stuschke, M., Balermpas, P., Rödel, C., Avlar, M., Grosu, A-L., Bayer, C., Belka, C., Pigorsch, S., Combs, S. E., Welz, S., Zips, D., Buchholz, F., Aust, D. E., Baretton, G. B., Thames, H. D., Dubrovska, A., Alsner, J., Overgaard, J., Baumann, M., Krause, M. & DKTK-ROG, 1 jun. 2016, I : Clinical Cancer Research. 22, 11, s. 2639-49 11 s.

Tumour stage and implementation of standardised cancer patient pathways: a comparative cohort study

Jensen, H., Tørring, M. L., Fenger-Grøn, M., Olesen, F., Overgaard, J. & Vedsted, P., 1 jun. 2016, I : British Journal of General Practice. 66, 647, s. 434-443

Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials

Toustrup, K., Sørensen, B. S., Metwally, M. A. H., Tramm, T., Mortensen, L. S., Overgaard, J. & Alsner, J., 10 maj 2016, I : Acta Oncologica. 55, 9-10, s. 1091-1098 8 s.

Pattern of relapse after breast conserving therapy, a study of 1519 early breast cancer patients treated in the Central Region of Denmark 2000-2009

Bodilsen, A., Offersen, B. V., Christiansen, P. & Overgaard, J., 6 maj 2016, I : Acta Oncologica. s. 1-6 6 s.

Failure pattern and salvage treatment after radical treatment of head and neck cancer

Pagh, A., Grau, C. & Overgaard, J., maj 2016, I : Acta Oncologica. 55, 5, s. 625-32 8 s.

Importance of margin width in breast-conserving treatment of early breast cancer

Bodilsen, A., Bjerre, K., Offersen, B. V., Vahl, P., Amby, N., Dixon, J. M., Ejlertsen, B., Overgaard, J. & Christiansen, P., maj 2016, I : Journal of Surgical Oncology. 113, 6, s. 609-15 7 s.

Incidence of and survival after glottic squamous cell carcinoma in Denmark from 1971 to 2011-A report from the Danish Head and Neck Cancer Group

Lyhne, N. M., Johansen, J., Kristensen, C. A., Andersen, E., Primdahl, H., Andersen, L. J., Oksbjerg, S. & Overgaard, J., maj 2016, I : European Journal of Cancer. 59, s. 46-56 11 s.

Failure pattern and survival after breast conserving therapy. Long-term results of the Danish Breast Cancer Group (DBCG) 89 TM cohort

Lyngholm, C. D., Laurberg, T., Alsner, J., Damsgaard, T. E., Overgaard, J. & Christiansen, P., 27 apr. 2016, I : Acta Oncologica. 55, 8, s. 983-992 10 s.

Radiation oncology in the era of precision medicine

Baumann, M., Krause, M., Overgaard, J., Debus, J., Bentzen, S. M., Daartz, J., Richter, C., Zips, D. & Bortfeld, T., apr. 2016, I : Nature Reviews. Cancer. 16, 4, s. 234-49 16 s.

DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer

Thorsen, L. B. J., Offersen, B. V., Danø, H., Berg, M., Jensen, I., Pedersen, A. N., Zimmermann, S. J., Brodersen, H-J., Overgaard, M. & Overgaard, J., 1 feb. 2016, I : Journal of Clinical Oncology. 34, 4, s. 314-20 7 s.

Bridging the valley of death: The new Radiotherapy & Oncology section "First in man - Translational innovations in radiation oncology"

Baumann, M. & Overgaard, J., feb. 2016, I : Radiotherapy & Oncology. 118, 2, s. 217-9 3 s.

Gene-expression Classifier in Papillary Thyroid Carcinoma: Validation and Application of a Classifier for Prognostication

Londero, S. C., Jespersen, M. L., Krogdahl, A., Bastholt, L., Overgaard, J., Schytte, S., Godballe, C., Alsner, J. & The Danish Thyroid Cancer Group – DATHYRCA (part of the DAHANCA organization), feb. 2016, I : Anticancer Research. 36, 2, s. 749-56 8 s.

Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent - A population based study from the DAHANCA group

Lyhne, N. M., Johansen, J., Kristensen, C. A., Andersen, E., Primdahl, H., Andersen, L. J., Bøje, C. R., Jensen, A. R. & Overgaard, J., feb. 2016, I : Radiotherapy & Oncology. 118, 2, s. 257-66 10 s.

Does age affect prognosis in salivary gland carcinoma patients? A national Danish study

Bjørndal, K., Larsen, S. R., Therkildsen, M. H., Kristensen, C. A., Charabi, B., Andersen, E., Overgaard, J., Schytte, S., Pedersen, H. B., Andersen, L. J., Johansen, J., Godballe, C. & Danish Head and Neck Cancer Group (DAHANCA) and Academy of Geriatric Cancer Research (AgeCare), 2016, I : Acta Oncologica. 55 Suppl 1, s. 19-22 4 s.

Collagen fragment biomarkers as serological biomarkers of lean body mass – a biomarker pilot study from the DAHANCA25B cohort and matched controls

Nedergaard, A., Dalgas, U., Primdahl, H., Johansen, J., Overgaard, J., Overgaard, K., Henriksen, K., Karsdal, M. A. & Lønbro, S., dec. 2015, I : Journal of Cachexia, Sarcopenia and Muscle. 6, 4, s. 335-342 8 s.

Danish retinoblastoma patients 1943-2013 - genetic testing and clinical implications

Gregersen, P. A., Urbak, S. F., Funding, M., Overgaard, J., Jensen, U. B. & Alsner, J., 23 okt. 2015, I : Acta Oncologica. s. 1-6 6 s.

Biology-guided adaptive radiotherapy (BiGART) is progressing towards clinical reality

Grau, C., Overgaard, J., Høyer, M., Tanderup, K., Lindegaard, J. C. & Muren, L. P., okt. 2015, I : Acta Oncologica. 54, 9, s. 1245-50 6 s.

External validation of a normal tissue complication probability model for radiation-induced hypothyroidism in an independent cohort

Rønjom, M. F., Brink, C., Bentzen, S. M., Hegedüs, L., Overgaard, J., Petersen, J. B. B., Primdahl, H. & Johansen, J., okt. 2015, I : Acta Oncologica. 54, 9, s. 1301-9 9 s.

Quality assurance of radiation therapy for head and neck cancer patients treated in DAHANCA 10 randomized trial

Hansen, C. R., Johansen, J., Kristensen, C. A., Smulders, B., Andersen, L. J., Samsøe, E., Andersen, E., Petersen, J. B. B., Overgaard, J. & Grau, C., okt. 2015, I : Acta Oncologica. 54, 9, s. 1669-73 5 s.

Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole

Metwally, M. A. H., Ali, R., Kuddu, M., Shouman, T., Strojan, P., Overgaard, J. & Grau, C., okt. 2015, I : Acta Oncologica. 54, 9, s. 1673-7 5 s.

The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma

Lyhne, N. M., Primdahl, H., Kristensen, C. A., Andersen, E., Johansen, J., Andersen, L. J., Evensen, J., Mortensen, H. R. & Overgaard, J., okt. 2015, I : Radiotherapy & Oncology. 117, 1, s. 91-98 8 s.

The usability of a 15-gene hypoxia classifier as a universal hypoxia profile in various cancer cell types

Sørensen, B. S., Knudsen, A. B., Wittrup, C. F., Nielsen, S., Aggerholm-Pedersen, N., Busk, M., Horsman, M., Høyer, M., Bouchelouche, P. N., Overgaard, J. & Alsner, J., sep. 2015, I : Radiotherapy & Oncology. 116, 3, s. 346-51 6 s.

Validation of a gene expression profile predictive of the risk of radiation-induced fibrosis in women treated with breast conserving therapy

Lyngholm, C. D., Overgaard, J., Christiansen, P. M. & Alsner, J., 12 aug. 2015, I : Acta Oncologica. s. 1-4 4 s.

The Influence of Repeat Surgery and Residual Disease on Recurrence After Breast-Conserving Surgery: A Danish Breast Cancer Cooperative Group Study

Bodilsen, A., Bjerre, K., Offersen, B. V., Vahl, P., Ejlertsen, B., Overgaard, J. & Christiansen, P., 16 jul. 2015, I : Annals of Surgical Oncology.

IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma

Metwally, M. A. H., Ali, R., Kuddu, M., Shouman, T., Strojan, P., Iqbal, K., Prasad, R., Grau, C. & Overgaard, J., jul. 2015, I : Radiotherapy & Oncology. 116, 1, s. 15-20 6 s.

Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study

Bentzen, J., Toustrup, K., Eriksen, J. G., Primdahl, H., Andersen, L. J. & Overgaard, J., jul. 2015, I : Acta Oncologica. 54, 7, s. 1001-7 7 s.

A longitudinal study of follow-up activities after curative treatment for head and neck cancer

Pagh, A., Grau, C. & Overgaard, J., maj 2015, I : Acta Oncologica. 54, 5, s. 813-9 7 s.

Predictors of continuous tobacco smoking in a clinical cohort study of Danish laryngeal cancer patients smoking before treated with radiotherapy

Møller, P. K., Tolstrup, J. S., Olsen, M. H., Dalton, S. O., Overgaard, J. & Johansen, J., maj 2015, I : Acta Oncologica. 54, 5, s. 685-92 8 s.

Socioeconomic position and stage at diagnosis of head and neck cancer - a nationwide study from DAHANCA

Olsen, M. H., Bøje, C. R., Kjær, T. K., Steding-Jessen, M., Johansen, C., Overgaard, J. & Dalton, S. O., maj 2015, I : Acta Oncologica. 54, 5, s. 759-66 8 s.

Diagnostic intervals before and after implementation of cancer patient pathways - a GP survey and registry based comparison of three cohorts of cancer patients

Jensen, H., Tørring, M. L., Olesen, F., Overgaard, J., Fenger-Grøn, M. & Vedsted, P., 23 apr. 2015, I : BMC Cancer. 15, 1, s. 308

Study of the Population Pharmacokinetic Characteristics of Nimorazole in Head and Neck Cancer Patients Treated in the DAHANCA-5 Trial

Metwally, M. A. H., Jansen, J. A. & Overgaard, J., mar. 2015, I : Clinical Oncology. 27, 3, s. 168-175 8 s.

Molecular signatures of local control in breast cancer

Tramm, T. & Overgaard, J., 2015, I : Breast Diseases; A Year Book Quarterly. 26, 1, s. 16-18 3 s.

Relative biological effectiveness of carbon ions for tumor control, acute skin damage and late radiation-induced fibrosis in a mouse model

Sørensen, B. S., Horsman, M. R., Alsner, J., Overgaard, J., Durante, M., Scholz, M., Friedrich, T. & Bassler, N., 2015, I : Acta Oncologica. 54, 9, s. 1623-1630 8 s.

Simultaneous Hypoxia and Low Extracellular pH Suppress Overall Metabolic Rate and Protein Synthesis In Vitro

Sørensen, B. S., Busk, M., Overgaard, J., Horsman, M. R. & Alsner, J., 2015, I : PLOS ONE. 10, 8, 14 s., e0134955.

Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer

Lassen, P., Primdahl, H., Johansen, J., Kristensen, C. A., Andersen, E., Andersen, L. J., Evensen, J. F., Eriksen, J. G., Overgaard, J. & Danish Head and Neck Cancer Group (DAHANCA), dec. 2014, I : Radiotherapy & Oncology. 113, 3, s. 310-6 7 s.

Risk of second non-breast cancer after radiotherapy for breast cancer: A systematic review and meta-analysis of 762,468 patients

Grantzau, T. & Overgaard, J., 7 nov. 2014, I : Radiotherapy & Oncology.

Papillary Thyroid Carcinoma in Denmark, 1996-2008: Outcome and Evaluation of Established Prognostic Scoring Systems in a Prospective National Cohort

Londero, S. C., Krogdahl, A., Bastholt, L., Overgaard, J., Pedersen, H. B., Hahn, C. H., Bentzen, J., Schytte, S., Christiansen, P., Gerke, O. & Godballe, C., 4 nov. 2014, I : Thyroid : official journal of the American Thyroid Association.

Effect of radiation on cell proliferation and tumor hypoxia in HPV-positive head and neck cancer in vivo models

Sørensen, B. S., Busk, M., Horsman, M. R., Alsner, J., Overgaard, J., Kyle, A. H. & Minchinton, A. I., nov. 2014, I : Anticancer Research. 34, 11, s. 6297-304 8 s.

Development and validation of a gene profile predicting benefit of postmastectomy radiotherapy in patients with high-risk breast cancer: a study of gene expression in the DBCG82bc cohort

Tramm, T., Mohammed, H., Myhre, S., Kyndi, M., Alsner, J., Børresen-Dale, A-L., Sørlie, T., Frigessi, A. & Overgaard, J., 15 okt. 2014, I : Clinical Cancer Research. 20, 20, s. 5272-80 9 s.

Heterogeneous and low-level methylation of novel biomarker candidates for breast cancer clinical management

Wojdacz, T. K., Windeløv, J. A., Thestrup, B. B., Damsgaard, T. E., Overgaard, J. & Hansen, L. L., okt. 2014, I : Cancer Research. 74, 19

Relationship between the prognostic and predictive value of the intrinsic subtypes and a validated gene profile predictive of loco-regional control and benefit from post-mastectomy radiotherapy in patients with high-risk breast cancer

Tramm, T., Kyndi, M., Myhre, S., Nord, S., Alsner, J., Sørensen, F. B., Sørlie, T. & Overgaard, J., okt. 2014, I : Acta Oncologica. 53, 10, s. 1337-46 10 s.

Cancer suspicion in general practice, urgent referral and time to diagnosis: a population-based GP survey and registry study

Jensen, H., Tørring, M. L., Olesen, F., Overgaard, J. & Vedsted, P., 30 aug. 2014, I : B M C Cancer. 14, 1, s. 636

Completeness and validity in a national clinical thyroid cancer database: DATHYRCA

Londero, S. C., Mathiesen, J. S., Krogdahl, A., Bastholt, L., Overgaard, J., Bentsen, J., Hahn, C. H., Schytte, S., Pedersen, H. B., Christiansen, P., Godballe, C. & A study from the Danish Thyroid Cancer Group, 14 aug. 2014, I : Cancer epidemiology.

CT-planned internal mammary node radiotherapy in the DBCG-IMN study: benefit versus potentially harmful effects

Thorsen, L. B. J., Thomsen, M. S., Berg, M., Jensen, I., Josipovic, M., Overgaard, M., Overgaard, J., Skogholt, P., Offersen, B. V. & Danish Breast Cancer Cooperative Group Radiotherapy committee, aug. 2014, I : Acta Oncologica. 53, 8, s. 1027-34 8 s.

Risk of second primary lung cancer in women after radiotherapy for breast cancer

Grantzau, T., Thomsen, M. S., Væth, M. & Overgaard, J., jun. 2014, I : Radiotherapy & Oncology. 111, 3, s. 366-73 8 s.

Compliance and toxicity of the hypoxic radiosensitizer nimorazole in the treatment of patients with head and neck squamous cell carcinoma (HNSCC)

Metwally, M. A. H., Frederiksen, K. D. & Overgaard, J., maj 2014, I : Acta Oncologica. 53, 5, s. 654-661 8 s.

The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors

Quigley, D. A., Fiorito, E., Nord, S., Van Loo, P., Alnæs, G. G., Fleischer, T., Tost, J., Moen Vollan, H. K., Tramm, T., Overgaard, J., Bukholm, I. R., Hurtado, A., Balmain, A., Børresen-Dale, A-L. & Kristensen, V., mar. 2014, I : Molecular Oncology. s. 273-84 12 s.

Identification and characterization of locus specific methylation patterns within novel loci undergoing hypermethylation during breast cancer pathogenesis

Wojdacz, T. K., Windeløv, J. A., Thestrup, B. B., Damsgaard, T. E., Overgaard, J. & Hansen, L. L., 3 feb. 2014, I : Breast Cancer Research (Online Edition). 16, 10 s., R17.

Evaluation of comorbidity in 9388 head and neck cancer patients: A national cohort study from the DAHANCA database

Bøje, C. R., Dalton, S. O., Primdahl, H., Kristensen, C. A., Andersen, E., Johansen, J., Andersen, L. J. & Overgaard, J., 8 jan. 2014, I : Radiotherapy & Oncology. s. 91-97 7 s.

Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c

Nygren, M. K., Tekle, C., Ingebrigtsen, V. A., Mäkelä, R., Krohn, M., Aure, M. R., Nunes-Xavier, C. E., Perälä, M., Tramm, T., Alsner, J., Overgaard, J., Nesland, J. M., Borgen, E., Børresen-Dale, A. L., Fodstad, O., Sahlberg, K. K. & Leivonen, S. K., 1 jan. 2014, I : B J C. 110, 8, s. 2072-2080 9 s.

LET-painting increases tumour control probability in hypoxic tumours

Bassler, N., Toftegaard, J., Lühr, A., Sørensen, B. S., Scifoni, E., Krämer, M., Jäkel, O., Mortensen, L. S., Overgaard, J. & Petersen, J. B., jan. 2014, I : Acta Oncologica. 53, 1, s. 25-32 8 s.

Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation

Søes, S., Daugaard, I. L., Sørensen, B. S., Carus, A., Mattheisen, M., Alsner, J., Overgaard, J., Hager, H., Hansen, L. L. & Kristensen, L. S., 2014, I : Oncoscience. 1, 5, s. 367-74 8 s.

Wound Healing – A Proteomic Analysis of the Effect of Erythropoietin on Granulation Tissue Isolated from ePTFE Implants

Christensen, B. A. O., Koudahl, V., Honoré, B., Overgaard, J., Damsgaard, T. E. & Vorum, H., 2014, I : Archives of Clinical and Experimental Surgery. 3, 1, s. 26-33 8 s.

Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection

Tramm, T., Hennig, G., Kyndi, M., Alsner, J., Sørensen, F. B., Myhre, S., Sørlie, T. & Overgaard, J., dec. 2013, I : Virchows Archiv. 463, 6, s. 775-786 12 s.

Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors

Aure, M. R., Leivonen, S-K., Fleischer, T., Zhu, Q., Overgaard, J., Alsner, J., Tramm, T., Louhimo, R., Alnæs, G. I., Perälä, M., Busato, F., Touleimat, N., Tost, J., Børresen-Dale, A-L., Hautaniemi, S., Troyanskaya, O. G., Lingjærde, O. C., Sahlberg, K. K. & Kristensen, V. N., 20 nov. 2013, I : Genome Biology. 14, 11, 20 s., R126.

The heat is (still) on - The past and future of hyperthermic radiation oncology

Overgaard, J., nov. 2013, I : Radiotherapy & Oncology. 109, 2, s. 185-187 3 s.

Independent prospective validation of a predictive test for risk of radiation induced fibrosis based on the gene expression pattern in fibroblasts irradiated in vitro

Andreassen, C. N., Overgaard, J. & Alsner, J., 3 okt. 2013, I : Radiotherapy & Oncology. 108, 3, s. 469-472 4 s.

Biology-guided adaptive radiotherapy (BiGART) - more than a vision?

Grau, C., Høyer, M., Alber, M., Overgaard, J., Lindegaard, J. C. & Muren, L. P., okt. 2013, I : Acta Oncologica. 52, 7, s. 1243-7 5 s.

Lean body mass and muscle function in head and neck cancer patients and healthy individuals - results from the DAHANCA 25 study.

Lønbro, S., Dalgas, U., Primdahl, H., Johansen, J., Nielsen, J. L., Overgaard, J. & Overgaard, K., okt. 2013, I : Acta Oncologica. 52, 7, s. 1543-51 9 s.

Expression of EGFR and HPV-associated p16 in oropharyngeal carcinoma: Correlation and influence on prognosis after radiotherapy in the randomized DAHANCA 5 and 7 trials

Lassen, P., Overgaard, J. & Eriksen, J. G., sep. 2013, I : Radiotherapy & Oncology. 108, 3, s. 489-94 6 s.

Molecular radiation biology/oncology at its best: Cutting edge research presented at the 13th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology

Baumann, M., Bodis, S., Dikomey, E., van der Kogel, A., Overgaard, J., Rodemann, H. P. & Wouters, B., sep. 2013, I : Radiotherapy & Oncology. 108, 3, s. 357-61 5 s.

Optimal reference genes for normalization of qRT-PCR data from archival formalin-fixed, paraffin-embedded breast tumors controlling for tumor cell content and decay of mRNA

Tramm, T., Sørensen, B. S., Overgaard, J. & Alsner, J., sep. 2013, I : Diagnostic Molecular Pathology. 22, 3, s. 181-187 7 s.

Papillary thyroid microcarcinoma in Denmark 1996-2008: A national study of epidemiology and clinical significance

Londero, S. C., Krogdahl, A., Bastholt, L., Overgaard, J., Trolle, W., Pedersen, H. B., Schytte, S., Bentzen, J., Christiansen, P. M. & Godballe, C., sep. 2013, I : Thyroid. 23, 9, s. 1159-64 6 s.

Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells

Sørensen, B. S., Busk, M., Olthof, N., Speel, E-J., Horsman, M. R., Alsner, J. & Overgaard, J., 13 aug. 2013, I : Radiotherapy & Oncology. 108, 3, s. 500-505 6 s.

Identification of accurate reference genes for RT-qPCR analysis of formalin-fixed paraffin-embedded tissue from primary Non-Small Cell Lung Cancers and brain and lymph node metastases.

Søes, S., Sørensen, B. S., Alsner, J., Overgaard, J., Hager, H., Hansen, L. L. & Kristensen, L. S., aug. 2013, I : Lung Cancer. 81, 2, s. 180-186 7 s.

Is regional nodes radiotherapy an alternative to surgery?

Offersen, B. V., Nielsen, H. M., Overgaard, M. & Overgaard, J., aug. 2013, I : Breast. 22, Suppl. 2, s. S118-S128 11 s.

Progressive resistance training rebuilds lean body mass in head and neck cancer patients after radiotherapy - Results from the randomized DAHANCA 25B trial

Lønbro, S., Dalgas, U., Primdahl, H., Johansen, J., Nielsen, J. L., Aagaard, P., Hermann, A. P., Overgaard, J. & Overgaard, K., aug. 2013, I : Radiotherapy & Oncology. 108, 2, s. 314-319 6 s.

Hypothyroidism after primary radiotherapy for head and neck squamous cell carcinoma: Normal tissue complication probability modeling with latent time correction

Rønjom, M. F., Brink, C., Bentzen, S., Hegedüs, L., Overgaard, J. & Johansen, J., 25 jul. 2013, I : Radiotherapy & Oncology. 109, 2, s. 317-322 6 s.

SNP in TXNRD2 Associated With Radiation-Induced Fibrosis: A Study of Genetic Variation in Reactive Oxygen Species Metabolism and Signaling

Edvardsen, H., Landmark-Høyvik, H., Reinertsen, K. V., Zhao, X., Grenaker-Alnæs, G. I., Nebdal, D., Syvänen, A-C., Rødningen, O., Alsner, J., Overgaard, J., Børresen-Dale, A-L., Fosså, S. D. & Kristensen, V. N., 15 jul. 2013, I : International Journal of Radiation Oncology, Biology, Physics. 86, 4, s. 791-799 9 s.

Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins

Myhre, S., Lingjærde, O-C., Hennessy, B. T., Aure, M. R., Carey, M. S., Alsner, J., Tramm, T., Overgaard, J., Mills, G. B., Børresen-Dale, A-L. & Sørlie, T., jun. 2013, I : Molecular Oncology. 7, 3, s. 704-18 15 s.

Long-term evaluation of postmastectomy breast reconstruction with the pedicled transverse rectus abdominis musculocutaneous flap

Christensen, B. O., Overgaard, J., Kettner, L. O. & Damsgaard, T. E., 28 maj 2013, I : Journal of Plastic Surgery and Hand Surgery. 47, 5, s. 374-378 5 s.

Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo

Horsman, M. R., Christensen, K. L. & Overgaard, J., apr. 2013, I : International Journal of Hyperthermia. 5, 2, s. 123-36 14 s.

In response to the commentary 'Particle species dependence of cell survival relative biological effectiveness: Evident and not negligible' by Thomas Friedrich, Marco Durante & Michael Scholz

Sørensen, B. S., Overgaard, J. & Bassler, N., apr. 2013, I : Acta Oncologica. 52, 3, s. 591 1 s.

Affiliation to the work market after curative treatment of head-and-neck cancer: a population-based study from the DAHANCA database

Kjær, T., Bøje, C. R., Olsen, M. H., Overgaard, J., Johansen, J., Ibfelt, E., Steding-Jessen, M., Johansen, C. & Dalton, S. O., feb. 2013, I : Acta Oncologica. 52, 2, s. 430-9 10 s.

Bleomycin, methotrexate and vincristine before irradiation of stage III and IV laryngeal and pharyngeal squamous cell carcinoma. A study initiated by the Danish Society of Head and Neck Cancer

Hansen, H. S., Rygård, J., Andersen, A. P., Munck-Hansen, J., Jørgensen, K., Overgaard, J., Sandberg, E. & Hansen, M. H., feb. 2013, I : Acta Oncologica. 26, 1, s. 13-8 6 s.

Feasibility and efficacy of progressive resistance training and dietary supplements in radiotherapy treated head and neck cancer patients - the DAHANCA 25A study

Lønbro, S., Dalgas, U., Primdahl, H., Overgaard, J. & Overgaard, K., feb. 2013, I : Acta Oncologica. 52, 2, s. 310-18 9 s.

Peritoneal macrophages mediated delivery of chitosan/siRNA nanoparticle to the lesion site in a murine radiation-induced fibrosis model

Nawroth, I., Alsner, J., Deleuran, B. W., Dagnæs-Hansen, F., Yang, C., Horsman, M. R., Overgaard, J., Howard, K., Kjems, J. & Gao, S., 1 jan. 2013, I : Acta Oncologica. 52, 8, s. 1730-1738 9 s.

PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice

Busk, M., Mortensen, L. S., Nordsmark, M., Overgaard, J., Jakobsen, S., Hansen, K. V., Theil, J., Kallehauge, J., D'Andrea, F. P., Steiniche, T. & Horsman, M. R., jan. 2013, I : European Journal of Nuclear Medicine and Molecular Imaging. 40, 2, s. 186-97 12 s.

Second primary cancers after adjuvant radiotherapy in early breast cancer patients: A national population based study under the Danish Breast Cancer Cooperative Group (DBCG)

Grantzau, T., Mellemkjær, L. & Overgaard, J., jan. 2013, I : Radiotherapy & Oncology. 106, 1, s. 42-49 8 s.

A proteomic analysis of the effect of radiation therapy on wound healing in women reconstructed with TRAM flap

Christensen, B. A. O., Overgaard, J., Vorum, H., Honoré, B. & Damsgaard, T. E., 2013, I : Advances in Bioscience and Biotechnology. 4, s. 1007-1012

Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assays

Wiechec, E., Overgaard, J., Kjeldsen, E. & Hansen, L. L., 2013, I : Cellular oncology (Dordrecht). Apr;36, 2, s. 113-120 8 s.

Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer

Mortensen, H. R., Overgaard, J., Jensen, K., Specht, L., Overgaard, M., Johansen, J., Evensen, J. F., Andersen, E. V., Andersen, L. J., Hansen, H. & Grau, C., 2013, I : Acta Oncologica. 52, 7, s. 1535-1542 8 s.

Long-term follow-up of late morbidity, cosmetic outcome and body image after breast conserving therapy. A study from the Danish Breast Cancer Cooperative Group (DBCG)

Lyngholm, C. D., Christiansen, P. M., Damsgaard, T. E. & Overgaard, J., 2013, I : Acta oncologica (Stockholm, Sweden). 52, 2, s. 259-69 11 s.

PET imaging of tumor hypoxia using 18F-labeled pimonidazole

Busk, M., Jakobsen, S., Horsman, M. R., Mortensen, L. S., Iversen, A. B., Overgaard, J., Nordsmark, M., Ji, X., Lee, D. Y. & Raleigh, J. R., 2013, I : Acta Oncologica. 52, 7, s. 1300-1307 8 s.

Papillary thyroid carcinoma in Denmark 1996-2008: an investigation of changes in incidence

Londero, S. C., Krogdahl, A., Bastholt, L., Overgaard, J., Pedersen, H. B., Frisch, T., Bentzen, J. D., Pedersen, P. U., Christiansen, P. & Godballe, C., 2013, I : Cancer Epidemiology. 37, 1, s. e1-6

Quality assurance of conventional non-CT-based internal mammary lymph node irradiation in a prospective Danish Breast Cancer Cooperative Group trial: The DBCG-IMN study

Thorsen, L. B. J., Thomsen, M. S., Overgaard, M., Overgaard, J. & Offersen, B. V., 2013, I : Acta Oncologica. 52, 7, s. 1526-34 9 s.

The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database

Bøje, C. R., Dalton, S. O., Grønborg, T. K., Primdahl, H., Kristensen, C. A., Andersen, E., Johansen, J., Andersen, L. J. & Overgaard, J., 2013, I : Acta Oncologica. 52, 2, s. 285-293 9 s.

The value of routine follow-up after treatment for head and neck cancer. A National Survey from DAHANCA

Pagh, A., Vedtofte, T., Lynggaard, C. D., Rubek, N., Lonka, M., Johansen, J., Andersen, E., Kristensen, C. A., von Buchwald, C., Andersen, M., Godballe, C., Overgaard, J. & Grau, C., 2013, I : Acta Oncologica. 52, 2, s. 277-84 8 s.

A community call for a dedicated radiobiological research facility to support particle beam cancer therapy

Holzscheiter, M. H., Bassler, N., Dosanjh, M., Sørensen, B. S. & Overgaard, J., okt. 2012, I : Radiotherapy & Oncology. 105, 1, s. 1-3

FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial

Mortensen, L. S., Johansen, J., Kallehauge, J. F., Primdahl, H., Busk, M., Lassen, P., Alsner, J., Sørensen, B. S., Toustrup, K., Jakobsen, S., Petersen, J., Petersen, H., Theil, J., Nordsmark, M. & Overgaard, J., okt. 2012, I : Radiotherapy & Oncology. 105, 1, s. 14-20 7 s.

Tumour microenvironment and radiation response in sarcomas originating from tumourigenic human mesenchymal stem cells

D'Andrea, F. P., Safwat, A. A., Burns, J. S., Kassem, M., Horsman, M. R. & Overgaard, J., jun. 2012, I : International Journal of Radiation Biology. 88, 6, s. 457-465 9 s.

Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002

Lyhne, N. M., Christensen, A., Alanin, M. C., Bruun, M. T., Jung, T. H., Bruhn, M. A., Jespersen, J. B. B., Kristensen, C. A., Andersen, E., Godballe, C., Buchwald, C., Bundgaard, T., Johansen, J., Lambertsen, K., Primdahl, H., Toustrup, K., Sørensen, J. A., Overgaard, J. & Grau, C., maj 2012, I : European Journal of Cancer. 49, 7, s. 1627-1633 7 s.

Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck

Toustrup, K., Sørensen, B. S., Lassen, P., Wiuf, C., Alsner, J., Overgaard, J. & Danish Head and Neck Cancer Group (DAHANCA), jan. 2012, I : Radiotherapy & Oncology. 102, 1, s. 122-129 8 s.

Breast irradiation profile. A gene expression signature predicting benefit of radiation therapy in breast cancer patients

Alsner, J., Tramm, T., Børresen-Dale, A. L., Frigessi, A., Mohammed, H., Myhre, S., Sørlie, T. & Overgaard, J., 2012, (Afsendt) IPC nr. U.S. Provisional Patent Application Serial No. 61/607,316

Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma--a prospective study

Hoff, C. M., Grau, C. & Overgaard, J., 2012, I : Radiotherapy & Oncology. 103, 1, s. 38-44 7 s.

Hypoxia gene expression signatures as prognostic and predictive markers in head and neck radiotherapy

Toustrup, K., Sørensen, B. S., Alsner, J. & Overgaard, J., 2012, I : Seminars in Radiation Oncology. 22, 2, s. 119-127 9 s.

Imaging hypoxia to improve radiotherapy outcome

Horsman, M. R., Mortensen, L. S., Petersen, J. B., Busk, M. & Overgaard, J., 2012, I : Nature Reviews. Clinical Oncology. 9, 12, s. 674-87 14 s.

Introduction: towards predicting outcome of radiotherapy-at last

Overgaard, J. & Bartelink, H., 2012, I : Seminars in Radiation Oncology. 22, 2, s. 87-90 4 s.

Method for determining clinically relevant hypoxia in cancer

Alsner, J., Toustrup, K., Sørensen, B. S., Wiuf, C. H., Nordsmark, M. & Overgaard, J., 2012, IPC nr. C12Q 1/68 (2006.01), A61K 31/415 (2006.01), A61K 31/4164 (2006.01) , Patentnr. WO/2012/146259, 1 nov. 2012

Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer

Mortensen, H. R., Overgaard, J., Specht, L., Overgaard, M., Johansen, J., Evensen, J. F., Andersen, L. J., Andersen, E. V. & Grau, C., 2012, I : Radiotherapy & Oncology. 103, 1, s. 69-75 7 s.

Salivary gland carcinoma in Denmark 1990-2005: Outcome and prognostic factors Results of the Danish Head and Neck Cancer Group (DAHANCA)

Bjørndal, K., Krogdahl, A., Therkildsen, M. H., Overgaard, J., Johansen, J., Kristensen, C. A., Homøe, P., Sørensen, C. H., Andersen, E. V., Bundgaard, T., Primdahl, H., Lambertsen, K., Andersen, L. J. & Godballe, C., 2012, I : Oral Oncology. 48, 2, s. 179-85 7 s.

Scoring and classification of oropharyngeal carcinoma based on HPV-related p16-expression

Lassen, P. & Overgaard, J., 2012, I : Radiotherapy & Oncology. 105, 2, s. 269-70 2 s.

Tumourigenicity and radiation resistance of mesenchymal stem cells

D'Andrea, F. P., Horsman, M. R., Kassem, M., Overgaard, J. & Safwat, A. A., 2012, I : Acta Oncologica. 51, 5, s. 669-679 11 s.

Dependence of cell survival on instantaneous dose rate of a linear accelerator

Sørensen, B. S., Vestergaard, A., Overgaard, J. & Præstegaard, L. H. P., okt. 2011, I : Radiotherapy & Oncology. 101, 1, s. 223-225 3 s.

Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials

Hoff, C., Lassen, P., Eriksen, J. G., Hansen, H. S., Specht, L., Overgaard, M., Grau, C., Johansen, J., Bentzen, J., Andersen, L., Evensen, J. F. & Overgaard, J., okt. 2011, I : Acta Oncologica. 50, 7, s. 1006-1014 9 s.

Long-term evaluation of postmastectomy breast reconstruction

Christensen, B. A. O., Overgaard, J., Kettner, L. O. & Damsgaard, T. E., okt. 2011, I : Acta Oncologica. 50, 7, s. 1053-61 9 s.

Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer

Toustrup, K., Sørensen, B. S., Nordsmark, M., Busk, M., Wiuf, C., Alsner, J. & Overgaard, J., sep. 2011, I : Cancer Research. 71, 17, s. 5923-31 9 s.

In vitro RBE-LET dependence for multiple particle types

Sørensen, B. S., Overgaard, J. & Bassler, N., aug. 2011, I : Acta Oncologica. 50, 6, s. 757-762

Functional proteomics can define prognosis and predict pathologic complete response in patients with breast cancer

Gonzalez-Angulo, A. M., Hennessy, B. T., Meric-Bernstam, F., Sahin, A., Liu, W., Ju, Z., Carey, M. S., Myhre, S., Speers, C., Deng, L., Broaddus, R., Lluch, A., Aparicio, S., Brown, P., Pusztai, L., Symmans, W. F., Alsner, J., Overgaard, J., Børresen-Dale, A-L., Hortobagyi, G. N., Coombes, K. R. & Mills, G. B., 8 jul. 2011, I : Clinical Proteomics. 8, 1, s. 11

Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance

D'Andrea, F. P., Safwat, A. A., Kassem, M., Gautier, L., Overgaard, J. & Horsman, M. R., jun. 2011, I : Radiotherapy & Oncology. 99, 3, s. 373-378 6 s.

High-resolution melting analysis for mutation screening of RGSL1, RGS16, and RGS8 in breast cancer

Wiechec, E., Wiuf, C., Overgaard, J. & Hansen, L. L., 1 mar. 2011, I : Cancer Epidemiology, Biomarkers & Prevention. 20, 2, s. 397-407 11 s.

High Resolution Melting (HRM) analysis for mutation screening of RGSL1,RGS16 and RGS8 in breast cancer.

Wiechec, E., Wiuf, C. H., Overgaard, J. & Hansen, L. L., 20 feb. 2011, I : Cancer Epidemiology, Biomarkers & Prevention. Feb;20(2), s. 397-407 11 s., doi: 10.1158/1055-9965.

In vivo Identification and Specificity assessment of mRNA markers of hypoxia in human and mouse tumors

Busk, M., Toustrup, K., Soerensen, B. S., Alsner, J., Horsman, M. R., Jakobsen, S. & Overgaard, J., 9 feb. 2011, I : B M C Cancer. 11, 1, s. 63

Resistance training and dietary supplements as intervention for regaining muscle mass following radiotherapy in head and neck cancer patients

Lønbro, S., Overgaard, K., Primdahl, H., Johansen, J. & Overgaard, J., feb. 2011, I : Radiotherapy & Oncology. 98, suppl. 1, s. S42 1 s.

Randomised controlled trials in HBO: "A call to arms" for HOPON & DAHANCA-21

Shaw, R., Forner, L., Butterworth, C., Jansen, E., Hillerup, S., Nutting, C. & Overgaard, J., 1 jan. 2011, I : British Journal of Oral and Maxillofacial Surgery. 49, 1, s. 76-77 2 s.

The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy--results from the randomized DAHANCA 5 study

Hoff, C. M., Hansen, H. S., Overgaard, M., Grau, C., Johansen, J., Bentzen, J. & Overgaard, J., 1 jan. 2011, I : Radiotherapy & Oncology. 98, 1, s. 28-33 6 s.

Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study

Mortensen, L. S., Busk, M., Nordsmark, M., Jakobsen, S., Theil, J., Overgaard, J. & Horsman, M. R., 2011, I : Radiotherapy & Oncology. 99, 3, s. 418-23 6 s.

Advancing radiation oncology through scientific publication--100 volumes of Radiotherapy and Oncology

Overgaard, J., 2011, I : Radiotherapy & Oncology. 100, 1, s. 1-6 6 s.

Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials

Hoff, C. M., Lassen, P., Eriksen, J. G., Hansen, H. S., Specht, L., Overgaard, M., Grau, C., Johansen, J., Bentzen, J. K. D., Andersen, L., Evensen, J. F. & Overgaard, J., 2011, I : Acta Oncologica. 50, 7, s. 1006-14 9 s.

Factors of importance for the development of the step-down heating effect in a C3H mammary carcinoma in vivo

Lindegaard, J. C. & Overgaard, J., 2011, I : International Journal of Hyperthermia. 3, 1, s. 79-91 13 s.

Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment

Busk, M., Walenta, S., Mueller-Klieser, W., Steiniche, T., Jakobsen, S., Horsman, M. R. & Overgaard, J., 2011, I : Radiotherapy & Oncology. s. 404-11 8 s.

Methylation of cancer related genes in tumor and peripheral blood DNA from the same breast cancer patient as two independent events

Wojdacz, T. K., Thestrup, B. B., Overgaard, J. & Hansen, L. L., 2011, I : Diagnostic Pathology. 6, 1, s. 116

No difference in the frequency of locus-specific methylation in the peripheral blood DNA of women diagnosed with breast cancer and age-matched controls

Wojdacz, T. K., Thestrup, B. B., Cold, S., Overgaard, J. & Hansen, L. L., 2011, I : Future Oncology. 7, 12, s. 1451-5 5 s.

Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA)

Bjørndal, K., Krogdahl, A., Therkildsen, M. H., Overgaard, J., Johansen, J., Kristensen, C. A., Homøe, P., Sørensen, C. H., Andersen, E. V., Bundgaard, T., Primdahl, H., Lambertsen, K., Andersen, L. J. & Godballe, C., 2011, I : Oral Oncology. 47, 7, s. 677-82 6 s.

Should Postmastectomy Radiotherapy to the Chest Wall and Regional Lymph Nodes Be Standard for Patients with 1-3 Positive Lymph Nodes?

Offersen, B. V., Brodersen, H-J., Nielsen, M. M., Overgaard, J. & Overgaard, M., 2011, I : Breast Care. 6, 5, s. 347-351 5 s.

Should postmastectomy radiotherapy to the chest wall and regional lymph nodes be standard for patients with 1–3 positive lymph nodes?

Offersen, B. V., Brodersen, H-J., Nielsen, M. M., Overgaard, J., Overgaard, M. & DBCG Radiotherapy Committee, 2011, I : Breast Care. 6, 5, s. 347-351 4 s.

The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial

Lassen, P., Eriksen, J. G., Krogdahl, A., Therkildsen, M. H., Ulhøi, B. P., Overgaard, M., Specht, L., Andersen, E. V., Johansen, J., Andersen, L. J., Grau, C., Overgaard, J. & Danish Head and Neck Cancer Group (DAHANCA), 2011, I : Radiotherapy & Oncology. 100, 1, s. 49-55 7 s.

In silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcome

Myhre, S., Mohammed, H., Tramm, T., Alsner, J., Finak, G., Park, M., Overgaard, J., Børresen-Dale, A-L., Frigessi, A. & Sørlie, T., 1 dec. 2010, I : P L o S One. 5, 11, s. e14002

Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival

Offersen, B. V., Knap, M. M., Horsman, M. R., Verheijen, J., Hanemaaijer, R. & Overgaard, J., 1 nov. 2010, I : Acta Oncologica. 49, 8, s. 1283-7 5 s.

Biology-guided adaptive radiation therapy - presence or future?

Grau, C., Olsen, D. R., Overgaard, J., Høyer, M., Lindegaard, J. C. & Muren, L., 1 okt. 2010, I : Acta Oncologica. 49, 7, s. 884-887 4 s.

Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode

Mortensen, L. S., Buus, S., Nordsmark, M., Bentzen, L. N., Munk, O. L., Keiding, S. & Overgaard, J., 1 okt. 2010, I : Acta Oncologica. 49, 7, s. 934-40 7 s.

Intraperitoneal administration of chitosan/DsiRNA nanoparticles targeting TNFα prevents radiation-induced fibrosis

Nawroth, I., Alsner, J., Behlke, M. A., Besenbacher, F., Overgaard, J., Howard, K. A. & Kjems, J., 1 okt. 2010, I : Radiotherapy & Oncology. 97, 1, s. 143-8 6 s.

Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro

Sørensen, B. S., Toustrup, K., Horsman, M. R., Overgaard, J. & Alsner, J., okt. 2010, I : Acta Oncologica. 49, 7, s. 895-905 11 s.

Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial

Overgaard, J., Mohanti, B. K., Begum, N., Ali, R., Agarwal, J. P., Kuddu, M., Bhasker, S., Tatsuzaki, H. & Grau, C., 1 jun. 2010, I : Lancet Oncology. 11, 6, s. 553-60 8 s.

Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?

Eriksen, J. G., Lassen, P. & Overgaard, J., 1 apr. 2010, I : Lancet Oncology. 11, 4, s. 312-3 2 s.

Leveraging clinical performance by technological excellence - The case of particle therapy

Olsen, D. R. & Overgaard, J., 1 apr. 2010, I : Radiotherapy & Oncology. 95, 1, s. 1-2 2 s.

Hyperfractionated or accelerated radiotherapy for head and neck cancer

Baujat, B., Bourhis, J., Blanchard, P., Overgaard, J., Ang, K. K., Saunders, M., Le Maître, A., Bernier, J., Horiot, J. C., Maillard, E., Pajak, T. F., Poulsen, M. G., Bourredjem, A., O'Sullivan, B., Dobrowsky, W., Andrzej, H., Skladowski, K., Hay, J. H., Pinto, L. H., Fu, K. K., Fallai, C., Sylvester, R., Pignon, J. P. & MARCH Collaborative Group, 1 jan. 2010, I : Cochrane Database of Systematic Reviews. 12, s. CD002026

A simple way to evaluate self-designed probes for tumor specific Multiplex Ligation-dependent Probe Amplification (MLPA).

Pedersen, K., Wiechec, E., Madsen, B. E., Overgaard, J. & Hansen, L. L., 2010, I : BMC Research Notes. 3, 1, s. 179 6 s.

A technical assessment of the utility of Reverse Phase Protein Arrays for the study of the functional proteome in non-microdissected human breast cancers

Hennessy, B. T., Lu, Y., Gonzalez-Angulo, A. M., Carey, M. S., Myhre, S., Ju, Z., Davies, M. A., Liu, W., Coombes, K., Meric-Bernstam, F., Bedrosian, I., McGahren, M., Agarwal, R., Zhang, F., Overgaard, J., Alsner, J., Neve, R. M., Kuo, W-L., Gray, J. W., Børresen-Dale, A-L. & Mills, G. B., 2010, I : Clinical Proteomics. 6, 4, s. 129-51 23 s.

Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET

Busk, M., Munk, O. L., Jakobsen, S., Wang, T., Skals, M., Steiniche, T., Horsman, M. R. & Overgaard, J., 2010, I : Acta Oncologica. 49, 7, s. 922-33 11 s.

HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer

Lassen, P., Eriksen, J. G., Hamilton-Dutoit, S., Tramm, T., Alsner, J. & Overgaard, J., 2010, I : Radiotherapy & Oncology. 94, 1, s. 30-5 6 s.

NimbleGen arrays and LightCycler 480 system: A complete workflow for DNA methylation biomarker discovery and validation

Wojdacz, T. K., Windeløv, J. A., Thestrup, B. B., Overgaard, J. & Hansen, L. L., 2010, I : Roche Application Note. 7 s.

Treatment of radiation-induced fibrosis

Kjems, J., Overgaard, J., Howard, K., Alsner, J., Besenbacher, F. & Nawroth, I., 2010, Patentnr. WO2010085959A1, 28 jan. 2010

Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast?

Busk, M., Horsman, M. R., Jakobsen, S., Hansen, K. V., Bussink, J., van der Kogel, A. & Overgaard, J., sep. 2009, I : Radiotherapy & Oncology. 92, 3, s. 429-436 7 s.

Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. 1996

Overgaard, J., Gonzalez Gonzalez, D., Hulshof, M. C. C. H., Arcangeli, G., Dahl, O., Mella, O. & Bentzen, S. M., aug. 2009, I : International Journal of Hyperthermia. 25, 5, s. 323-34 11 s.

Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)

Valentini, V., Aristei, C., Glimelius, B., Minsky, B. D., Beets-Tan, R., Borras, J. M., Haustermans, K., Maingon, P., Overgaard, J., Pahlman, L., Quirke, P., Schmoll, H-J., Sebag-Montefiore, D., Taylor, I., Van Cutsem, E., Van de Velde, C., Cellini, N. & Latini, P., aug. 2009, I : Radiotherapy & Oncology. 92, 2, s. 148-63 15 s.

Chemoradiotherapy of head and neck cancer--can the bumble bee fly?

Overgaard, J., jul. 2009, I : Radiotherapy & Oncology. 92, 1, s. 1-3 3 s.

Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer

Agarwal, R., Gonzalez-Angulo, A-M., Myhre, S., Carey, M., Lee, J-S., Overgaard, J., Alsner, J., Stemke-Hale, K., Lluch, A., Neve, R. M., Kuo, W. L., Sorlie, T., Sahin, A., Valero, V., Keyomarsi, K., Gray, J. W., Børresen-Dale, A-L., Mills, G. B. & Hennessy, B. T., 1 jun. 2009, I : Clinical Cancer Research. 15, 11, s. 3654-3662 8 s.

Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck

Lassen, P., Eriksen, J. G., Hamilton-Dutoit, S., Tramm, T., Alsner, J. & Overgaard, J., 20 apr. 2009, I : Journal of Clinical Oncology. 27, 12, s. 1992-8 7 s.

Intra-voxel heterogeneity influences the dose prescription for dose-painting with radiotherapy: a modelling study

Petit, S. F., Dekker, A. L. A. J., Seigneuric, R., Murrer, L., van Riel, N. A. W., Nordsmark, M., Overgaard, J., Lambin, P. & Wouters, B. G., 7 apr. 2009, I : Physics in Medicine and Biology. 54, 7, s. 2179-96 17 s.

Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: A systematic review

Offersen, B. V., Overgaard, M., Kroman, N. & Overgaard, J., jan. 2009, I : Radiotherapy & Oncology. 90, 1, s. 1-13 13 s.

High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: A subgroup analysis of DBCG 82 b

Kyndi, M., Overgaard, M., Nielsen, H. M., Sørensen, F. B., Knudsen, H. & Overgaard, J., jan. 2009, I : Radiotherapy & Oncology. 90, 1, s. 74-9 6 s.

Hyperthermia classic commentary: 'Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology' by J. Overgaard, D. Gonzalez Gonzalez, M.C.C.H. Hulshof, G. Arcangeli, O. Dahl, O. Mella & S.M. Bentzen, International Journal of Hyperthermia 1996;12:3-20

van der Zee, J. & Overgaard, J., 2009, I : International Journal of Hyperthermia. 25, 5, s. 335-337

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients

Pignon, J-P., le Maître, A., Maillard, E., Bourhis, J., Amand, C., Armand, JP., Luboinski, B., Lefebvre, JL., Syz, N., Bernier, J., Budach, V., Forastiere, AA., Stewart, AA., Vokes, EE., Adelstein, DJ., Audry, H., Bachaud, JM., Bartelink, HG., Bezwoda, WR., Buffoli, A., Bhowmik, KT., Browman, GP., Calais, G., Campbell, BH., Carugati, A., Chalkidou, S., Clark, JR., Cohen, E., Collette, L., Dal Canton, O., Dalley, D., Despondt, J., Désigné, L., Deszcz-Thomas, A., Di Blasio, B., Dobrowsky, W., Domenge, C., Eschwege, F., Evensen, JF., Fallai, C., Fischer, JJ., Forastière, AA., Fountzilas, G., Fu, KK., Gedouin, D., Guérin, S., Geara, F., Giglio, R., Gupta, NK., Haddad, E., Haffy, BG., Hasegawa, Y., Hill, C., Horiot, JC., Horiuchi, M., Houghton, J., Huguenin, P., Jan, P., Jaulerry, C., Jeremic, B., Jouffroy, T., Jortay, A., Kapstad, B., Kowalski, LP., Kramer, S., Krishnamurthi, KS., Kumar, S., Laramore, G., Lartigau, E., Lefebvre, JL., Leong, T., Lewin, F., Luboinski, B., Luboinski, M., Maipang, T., Martin, M., Mazeron, JJ., Merlano, M., Metha, S., Molinari, R., Monson, K., Morita, K., Mueller, RP., Murias, A., Mosseri, V., Numico, G., Olmi, P., O'Sullivan, B., Overgaard, J., Paccagnella, A., Pajak, T., Parvinen, LM., Pearlman, NW., Rao, RS., Richard, JM., Rufibach, K., Sanchiz, F., Sancho-Garnier, H., Schuller, DE., Shanta, V., Shanta, V., Simes, RJ., Smid, L., Stewart, LA., Staar, S., Strojan, P., Stuetzer, H., Szpirglas, H., Schwaab, G., Takaku, S., Taylor, SG., Taylor, SG., Tobias, JS., Toohill, RJ., Vokes, EE., Volling, P., Weissler, MC., Wendt, T., Wernecke, KD., Widder, J. & Wolf, GT., 2009, I : Radiotherapy & Oncology. 92, 1, s. 4-14 10 s.

Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics

Sørensen, B. S., Horsman, M. R., Vorum, H., Honoré, B., Overgaard, J. & Alsner, J., 2009, I : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 92, 3, s. 443-9 6 s.

Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data

Michiels, S., Le Maître, A., Buyse, M., Burzykowski, T., Maillard, E., Bogaerts, J., Vermorken, J. B., Budach, W., Pajak, T. F., Ang, K. K., Bourhis, J., Pignon, J-P., MARCH and MACH-NC Collaborative Groups, Bernier, J., Budach, V., Brizel, D., Chalkidou, S., Cohen, E., Calais, G., Dowbrowsky, W., Fallai, C., Giglio, R., Horiot, JC., Huguenin, P., Jaulerry, C., Monson, K., Olmi, P., Overgaard, J., Rufibach, K., Stuetzer, H., Wernecke, KD., Syz, N., Amand, C., Mekranter, B. & Midavaine, M., 2009, I : Lancet Oncology. 10, 4, s. 341-50 9 s.

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage

Busk, M., Horsman, M. R., Jakobsen, S., Bussink, J., van der Kogel, A. & Overgaard, J., dec. 2008, I : European Journal of Nuclear Medicine and Molecular Imaging. 35, 12, s. 2294-303 10 s.

Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia

Busk, M., Horsman, M. R., Kristjansen, P. E. G., van der Kogel, A. J., Bussink, J. & Overgaard, J., 15 jun. 2008, I : International Journal of Cancer. 122, 12, s. 2726-34 9 s.

Genetic markers for prediction of normal tissue toxicity after radiotherapy

Alsner, J., Andreassen, C. N. & Overgaard, J., apr. 2008, I : Seminars in Radiation Oncology. 18, 2, s. 126-35 9 s.

Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group

Kyndi, M., Sørensen, F. B., Knudsen, H., Overgaard, M., Nielsen, H. M., Overgaard, J. & Danish Breast Cancer Cooperative Group, 20 mar. 2008, I : Journal of Clinical Oncology. 26, 9, s. 1419-26 7 s.

Imaging Hypoxia in Xenografted and Murine Tumors with 18F-Fluoroazomycin Arabinoside: A Comparative Study Involving microPET, Autoradiography, pO2-Polarography, and Fluorescence Microscopy

Busk, M., Horsman, M. R., Jakobsen, S., Keiding, S., van der Kogel, A. J., Bussink, J. & Overgaard, J., 15 mar. 2008, I : International Journal of Radiation Oncology, Biology, Physics. 70, 4, s. 1202-12 11 s.

Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials

Kyndi, M., Sørensen, F. B., Knudsen, H., Alsner, J., Overgaard, M., Nielsen, H. M., Overgaard, J. & Danish Breast Cancer Cooperative Group, mar. 2008, I : Breast Cancer Research (Online Edition). 10, 2, s. R24 1 s.

In normal human fibroblasts variation in DSB repair capacity cannot be ascribed to radiation-induced changes in the localisation, expression or activity of major NHEJ proteins

Kasten-Pisula, U., Vronskaja, S., Overgaard, J. & Dikomey, E., mar. 2008, I : Radiotherapy & Oncology. 86, 3, s. 321-328 8 s.

Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis

Rødningen, O. K., Børresen-Dale, A-L., Alsner, J., Hastie, T. & Overgaard, J., mar. 2008, I : Radiotherapy & Oncology. 86, 3, s. 314-320 7 s.

Antiproton radiotherapy

Bassler, N., Alsner, J., Beyer, G., DeMarco, J. J., Doser, M., Hajdukovic, D., Hartley, O., Iwamoto, K. S., Jäkel, O., Knudsen, H. V., Kovacevic, S., Møller, S. P., Overgaard, J., Petersen, J. B., Solberg, T. D., Sørensen, B. S., Vranjes, S., Wouters, B. G. & Holzscheiter, M. H., jan. 2008, I : Radiotherapy & Oncology. 86, 1, s. 14-19 6 s.

A comparison among HER2, TP53, PAI-1, angiogenesis, and proliferation activity as prognostic variables in tumours from 408 patients diagnosed with early breast cancer

Offersen, B. V., Alsner, J., Ege Olsen, K., Riisbro, R., Brünner, N., Sørensen, F. B., Sørensen, B. S., Schlemmer, B. O. & Overgaard, J., 2008, I : Acta Oncologica. 47, 4, s. 618-32 15 s.

A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients

Alsner, J., Jensen, V., Kyndi, M., Offersen, B. V., Vu, P., Børresen-Dale, A-L. & Overgaard, J., 2008, I : Acta Oncologica. 47, 4, s. 600-7 8 s.

A fragile site within the HPC1 region at 1q25.3 affecting RGS16, RGSL1 and RGSL2 in human breast carcinomas

Wiechec, E., Overgaard, J. & Hansen, L. L., 2008, I : Genes, Chromosomes & Cancer. 47, s. 766-780

Antiproton therapy

Knudsen, H., Holzscheiter, M. H., Bassler, N., Alsner, J., Beyer, G., DeMarco, J. J., Doser, M., Hajdukovic, D., Hartley, O., Iwamoto, K. S., Jäkel, O., Kovacevic, S., Møller, S. P., Overgaard, J., Petersen, J. B. B., Ratib, O., Solberg, T. D., Vranjes, S., Wouters, B. G. & the CERN ACE Collaboration, 2008, I : Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms. 266, 3, s. 530-534

DBCG: the Danish Breast Cancer Cooperative Group - a 30-year struggle for better breast cancer treatment in Denmark

Overgaard, J., 2008, I : Acta Oncologica. 47, 4, s. 491-6 6 s.

Does the introduction of sentinel node biopsy increase the number of node positive patients with early breast cancer? A population based study form the Danish Breast Cancer Cooperative Group

Madsen, A. H., Jensen, A. R., Christiansen, P., Garne, J. P., Cold, S., Ewertz, M. & Overgaard, J., 2008, I : Acta Oncologica. 47, 2, s. 239-47 8 s.

Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer.

Madsen, B. E., Ramos, E. M., Boulard, M., Duda, K., Overgaard, J., Nordsmark, M., Wiuf, C. & Hansen, L. L., 2008, I : P L o S One. 3, 6, s. e2492

Image-guided adaptive radiotherapy - integration of biology and technology to improve clinical outcome

Grau, C., Muren, L., Høyer, M., Lindegaard, J. & Overgaard, J., 2008, I : Acta Oncologica. 47, 7, s. 1182-1185 4 s.

Impact of BCL2 and p53 on postmastectomy radiotherapy response in high-risk breast cancer. A subgroup analysis of DBCG82 b&c.

Kyndi, M., Sørensen, F. B., Knudsen, H., Alsner, J., Overgaard, M., Nielsen, H. M. & Overgaard, J., 2008, I : Acta Oncologica. 47, 4, s. 608-617 10 s.

Novel methods for treating EGFR-associated tumors

Overgaard, J., 2008, IPC nr. A61K 39/395 (2006.01), A61K 41/00 (2006.01), A61N 5/10 (2006.01), C07K 16/28 (2006.01), Patentnr. WO/2008/154927, 24 dec. 2008

Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study

Johansen, J., Buus, S., Loft, A., Keiding, S., Overgaard, M., Hansen, H. S., Grau, C., Bundgaard, T., Kirkegaard, J. & Overgaard, J., 2008, I : Head & Neck (Print Edition). 30, 4, s. 471-8 7 s.

Resolution in PET hypoxia imaging: voxel size matters

Busk, M., Horsman, M. R. & Overgaard, J., 2008, I : Acta Oncologica. 47, 7, s. 1201-10 10 s.

Shoulder disability and late symptoms following surgery for early breast cancer

Lauridsen, M. C., Overgaard, M., Overgaard, J., Hessov, I. B. & Christiansen, P. M., 2008, I : Acta Oncologica. 47, 4, s. 569-75 6 s.

The impact of hypoxia on the activity of lactate dehydrogenase in two different pre-clinical tumour models

Lukacova, S., Sørensen, B., Alsner, J., Overgaard, J. & Horsman, M., 2008, I : Acta Oncologica. 47, 5, s. 941-47 7 s.

Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b

Kyndi, M., Sørensen, F. B., Knudsen, H., Overgaard, M., Nielsen, H. M., Andersen, J. & Overgaard, J., 2008, I : Acta Oncologica. 47, 4, s. 591-599 8 s.

Trends in breast cancer during three decades in Denmark: stage at diagnosis, surgical management and survival

Jensen, A. R., Madsen, A. H. & Overgaard, J., 2008, I : Acta Oncologica. 47, 4, s. 537-44 8 s.

Hyperthermia: a potent enhancer of radiotherapy

Horsman, M. R. & Overgaard, J., aug. 2007, I : Clinical Oncology. 19, 6, s. 418-426 9 s.

Differential gene expression before and after ionizing radiation of subcutaneous fibroblasts identifies breast cancer patients resistant to radiation-induced fibrosis

Alsner, J., Rødningen, O. K. & Overgaard, J., jun. 2007, I : Radiotherapy & Oncology. 83, 3, s. 261-266 6 s.

Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients

Nordsmark, M., Eriksen, J. G., Gebski, V., Alsner, J., Horsman, M. R. & Overgaard, J., jun. 2007, I : Radiotherapy & Oncology. 83, 3, s. 389-397 9 s.

Hypoxia induced expression of endogenous markers in vitro is highly influenced by pH

Sørensen, B. S., Alsner, J., Overgaard, J. & Horsman, M. R., jun. 2007, I : Radiotherapy & Oncology. 83, 3, s. 362-366

Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: An evaluation of the DAHANCA 5 study

Eriksen, J. G. & Overgaard, J., jun. 2007, I : Radiotherapy & Oncology. 83, 3, s. 383-388 6 s.

Translational research in radiotherapy - Getting closer to the bedside

Overgaard, J. & Baumann, M., jun. 2007, I : Radiotherapy & Oncology. 83, 3, s. 217-219 3 s.

Translational research in radiotherapy - getting closer to the bedside

Overgaard, J. & Baumann, M., jun. 2007, I : Radiotherapy & Oncology. 83, 3, s. 217-219 3 s.

Reproductive death of cancer cells induced by femtosecond laser pulses

Thøgersen, J., Knudsen, C. S., Maetzke, A., Jensen, S. K., Keiding, S. R., Alsner, J. & Overgaard, J., maj 2007, I : International Journal of Radiation Biology. 83, 5, s. 289-99 11 s.

Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b & c randomized trials

Overgaard, M., Nielsen, H. M. & Overgaard, J., mar. 2007, I : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 82, 3, s. 247-253 7 s.

Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis

Offersen, B. V., Pfeiffer, P., Andreasen, P. & Overgaard, J., jan. 2007, I : Lung Cancer. 56, 1, s. 43-50 8 s.

Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation

Johansen, J., Overgaard, J. & Overgaard, M., 2007, I : Acta Oncologica. 46, 4, s. 525-533 9 s.

Hypoxic radiosensitization: adored and ignored

Overgaard, J., 2007, I : Journal of Clinical Oncology. 25, 26, s. 4066-74 8 s.

Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancer

Danish Breast Cancer Cooperative Group (DBCG) Tumor Biology Committee, 2007, I : Acta Oncologica. 46, 6, s. 782-91 9 s.

Late neurological complications after irradiation of malignant tumors of the testis

Knap, M., Bentzen, S. M. & Overgaard, J., 2007, I : Acta Oncologica. 46, 4, s. 497-503 7 s.

Postmastectomy radiotherapy should be the standard of care for all women with involved axillary nodes

Poortmans, P., Overgaard, M. & Overgaard, J., 2007, I : Radiotherapy & Oncology. 84, s. 104-105 2 s.

Predisposition to, prognosis and treatment regime for breast cancer using genetic markers on chromosome 13

Hansen, L. L. & Overgaard, J., 2007, Patentnr. 60/884,980

Predisposition to, prognosis for and treatment of breast cancer relating to human chromosome 1 (absence)

Hansen, L. L. & Overgaard, J., 2007, Patentnr. PA 2007 00059

Predisposition to, prognosis for and treatment of breast cancer relating to human chromosome 1 (presence)

Hansen, L. L. & Overgaard, J., 2007, Patentnr. PA 2007 00060

Predisposition to, prognosis for and treatment of breast cancer relating to human chromosome 16

Hansen, L. L. & Overgaard, J., 2007, Patentnr. PA 2007 00052

Predisposition to, prognosis for and treatment of breast cancer using genetic markers on  chromosome 13

Hansen, L. L. & Overgaard, J., 2007, Patentnr. PA 2007 00057

Predisposition to, prognosis for and treatment regime for breast cancer relating to human chromosome 16

Hansen, L. L. & Overgaard, J., 2007, Patentnr. 60/884,975

Randomized study of the importance of Novel Erythropoiesis Stimulating Protein (Aranesp (R)) for the effect of radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC) - the Danish Head and Neck Cancer Group DAHANCA 10 randomized trial.

Overgaard, J., Hoff, C., Sand Hansen, H., Specht, L., Overgaard, M., Grau, C., Andersen, E., Johansen, J., Andersen, L. J. & Evensen, J., 2007, I : European Journal of Cancer Supplements. 5, 6, s. 7 1 s.

Tumor progression in waiting time for radiotherapy in head and neck cancer

Jensen, A. R., Nellemann, H. M. & Overgaard, J., 2007, I : Radiotherapy & Oncology. 84, 1, s. 5-10 5 s.

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

Bourhis, J., Overgaard, J., Audry, H., Ang, K. K., Saunders, M., Bernier, J., Horiot, J. C., Le Maître, A., Pajak, T. F., Poulsen, M. G., O'Sullivan, B., Dobrowsky, W., Hliniak, A., Skladowski, K., Hay, J. H., Pinto, L. H. J., Fallai, C., Fu, K. K., Sylvester, R. & Pignon, J-P., 2 sep. 2006, I : Lancet. 368, 9538, s. 843-854 12 s.

Bridging gaps in translational radiation oncology

Bernier, J. & Overgaard, J., aug. 2006, I : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 80, 2, s. 109-111 3 s.

Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM - a study based on DNA from formalin fixed paraffin embedded tissue samples

Andreassen, C. N., Alsner, J., Overgaard, M., Sørensen, F. B. & Overgaard, J., aug. 2006, I : International Journal of Radiation Biology. 82, 8, s. 577-586 10 s.

Strain and tumour specific variations in the effect of hypoxia on osteopontin levels in experimental models

Lukácová, S., Overgaard, J., Alsner, J. & Horsman, M. R., aug. 2006, I : Radiotherapy & Oncology. 80, 2, s. 165-171 7 s.

The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study

Nordsmark, M., Loncaster, J., Aquino-Parsons, C., Chou, S-C., Gebski, V., West, C., Lindegaard, J., Havsteen, H., Davidson, S. E., Hunter, R., Raleigh, J. A. & Overgaard, J., aug. 2006, I : Radiotherapy & Oncology. 80, 2, s. 123-131 9 s.

Genetic Predictors of Adverse Radiotherapy Effects: the Gene-PARE project

Ho, A. Y., Atencio, D. P., Peters, S., Stock, R. G., Formenti, S. C., Cesaretti, J. A., Green, S., Haffty, B., Drumea, K., Leitzin, L., Kuten, A., Azria, D., Ozsahin, M., Overgaard, J., Andreassen, C. N., Trop, C. S., Park, J. & Rosenstein, B. S., 1 jul. 2006, I : International Journal of Radiation Oncology, Biology, Physics. 65, 3, s. 646-655 10 s.

Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies

Nielsen, H. M., Overgaard, M., Grau, C., Jensen, A. R. & Overgaard, J., 20 maj 2006, I : Journal of Clinical Oncology. 24, 15, s. 2268-2275 8 s.

Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials

Nielsen, H. M., Overgaard, M., Grau, C., Jensen, A. R. & Overgaard, J., maj 2006, I : Radiotherapy & Oncology. 79, 2, s. 147-55 9 s.

Uveal and conjunctival malignant melanoma in denmark 1943-97: observed and relative survival of patients followed through 2002

Isager, P., Engholm, G., Overgaard, J. & Storm, H., apr. 2006, I : Ophthalmic Epidemiology. 13, 2, s. 85-96 12 s.

ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy

Andreassen, C. N., Overgaard, J., Alsner, J., Overgaard, M., Herskind, C., Cesaretti, J. A., Atencio, D. P., Green, S., Formenti, S. C., Stock, R. G. & Rosenstein, B. S., 1 mar. 2006, I : International Journal of Radiation Oncology, Biology, Physics. 64, 3, s. 776-783 8 s.

The emerging evidence for Stereotactic Body Radiotherapy

Grau, C., Høyer, M., Lindegaard, J. C. & Overgaard, J., 1 jan. 2006, I : Acta Oncologica. 45, 7, s. 771-774 4 s.

Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx and pharynx: A Danish nationwide survey from DAHANCA

Primdahl, H., Nielsen, A. L., Larsen, S., Andersen, E., Ipsen, M., Lajer, C., Vestermark, L. W., Andersen, L. J., Hansen, H. S., Overgaard, M., Overgaard, J. & Grau, C., 2006, I : Acta Oncologica. 45, s. 156-161

Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: a Danish nationwide survey from DAHANCA

Primdahl, H., Nielsen, A. L., Larsen, S., Andersen, E., Ipsen, M., Lajer, C., Vestermark, L. W., Andersen, L. J., Hansen, H. S., Overgaard, M., Overgaard, J., Grau, C. & DAHANCA, 2006, I : Acta Oncologica. 45, 2, s. 156-161 6 s.

Is expression of the epidermal growth factor receptor related to hypoxia in squamous cell carcinomas of the head and neck - an evaluation of the DAHANCA 5 study

Eriksen, J. G., Nordsmark, M., Alsner, J., Horsman, M. R., Steinicke, T. & Overgaard, J., 2006, Radiother Oncol. 78 (Suppl.1) udg. s. S38 1 s.

LOH rather than genotypes of TP53 codon 72 is associated with disease-free survival in primary breast cancer

Kyndi, M., Alsner, J., Hansen, L. L., Sørensen, F. B. & Overgaard, J., 2006, I : Acta oncologica (Stockholm, Sweden). 45, 5, s. 602-609 8 s.

Preclinical studies in murine tumours to elucidate the role of serum osteopontin as an endogenous marker of hypoxia

Lukacova, S., Khalil, A. A., Overgaard, J., Alsner, J. & Horsman, M. R., 2006, Radiother. Oncol.. 78 (Suppl.1) udg. s. S31 1 s.

Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response

Horsman, M. R., Nielsen, T., Østergaard, L. & Overgaard, J., 2006, I : Acta Oncologica. 45, 7, s. 876-80 5 s.

Radiotherapy in early breast cancer

Fourquet, A., Overgaard, J. & Yarnold, J., 2006, I : EJC SUPPLEMENTS. 4, 2, s. 10-12 3 s.

Visual outcome, local tumour control, and eye preservation after 106Ru/Rh brachytherapy for choroidal melanoma

Isager, P., Ehlers, N., Urbak, S. F. & Overgaard, J., 2006, I : Acta Oncologica. 45, 3, s. 285-93 9 s.

Microarray analysis of the transcriptional response to single or multiple doses of ionizing radiation in human subcutaneous fibroblasts

Rødningen, O. K., Overgaard, J., Alsner, J., Hastie, T. & Børresen-Dale, A-L., dec. 2005, I : Radiotherapy & Oncology. 77, 3, s. 231-240 10 s.

Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serum

Lukácová, S., Khalil, A. A., Overgaard, J., Alsner, J. & Horsman, M. R., dec. 2005, I : International Journal of Radiation Biology. 81, 12, s. 937-944 8 s.

Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group

Knoop, A. S., Knudsen, H., Balslev, E., Rasmussen, B. B., Overgaard, J., Nielsen, K. V., Schonau, A., Gunnarsdóttir, K., Olsen, K. E., Mouridsen, H. & Ejlertsen, B., dec. 2005, I : Journal of Clinical Oncology. 23, 30, s. 7483-7490 8 s.

Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: Results from the DAHANCA 5 randomised double-blind placebo-controlled trial

Overgaard, J., Eriksen, J. G., Nordsmark, M., Alsner, J. & Horsman, M. R., okt. 2005, I : Lancet Oncology. 6, 10, s. 757-764 8 s.

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

Nordsmark, M., Bentzen, S. M., Rudat, V., Brizel, D., Lartigau, E., Stadler, P., Becker, A., Adam, M., Molls, M., Dunst, J., Terris, D. J. & Overgaard, J., okt. 2005, I : Radiotherapy & Oncology. 77, 1, s. 18-24 7 s.

Audit of the radiotherapy in the DBCG 82 b&c trials - A validation study of the 1538 patients randomised to postmastectomy radiotherapy

Nielsen, H. M., Overgaard, J., Grau, C., Christensen, J. J. & Overgaard, M., sep. 2005, I : Radiotherapy & Oncology. 76, 3, s. 285-292 8 s.

ESTRO-Wolfsberg a synergistic approach towards modern radiobiology

Overgaard, J. & van der Kogel, A., aug. 2005, I : Radiotherapy & Oncology. 76, 2, s. 109-111 3 s.

Influence of oxygen concentration and pH on expression of hypoxia induced genes

Sørensen, B. S., Hao, J., Overgaard, J., Vorum, H., Honore, B., Alsner, J. & Horsman, M. R., aug. 2005, I : Radiotherapy & Oncology. 76, 2, s. 187-193 7 s.

The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times

Eriksen, J. G., Alsner, J., Steiniche, T. & Overgaard, J., aug. 2005, I : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 76, 2, s. 135-142 8 s.

Uveal and conjunctival malignant melanoma in Denmark, 1943-97: incidence and validation study

Isager, P., Østerlind, A., Engholm, G., Heegaard, S., Lindegaard, J., Overgaard, J. & Storm, HH., aug. 2005, I : Ophthalmic Epidemiology. 12, 4, s. 223-232 10 s.

Long-term anorectal dysfunction after postoperative radiotherapy for rectal cancer

Lundby, L., Krogh, K., Jensen, T. V., Gandrup, P., Qvist, N., Overgaard, J. & Laurberg, S., jul. 2005, I : Diseases of the Colon and Rectum. 48, 7, s. 1349-52 4 s., Author reply 1352.

Familial cancer associated with a polymorphism in ARLTS1

Calin, G. A., Trapasso, F., Shimizu, M., Dumitru, C. D., Yendamuri, S., Godwin, A. K., Ferracin, M., Bernardi, G., Chatterjee, D., Baldassarre, G., Rattan, S., Alder, H., Mabuchi, H., Shiraishi, T., Hansen, L. L., Overgaard, J., Herlea, V., Mauro, F. R., Dighiero, G., Movsas, B., Rassenti, L., Kipps, T., Baffa, R., Fusco, A., Mori, M., Russo, G., Liu, C-G., Neuberg, D., Bullrich, F., Negrini, M. & Croce, C. M., 21 apr. 2005, I : N. Engl. J. Med.. 352, 16, s. 1667-1676 10 s.

Familial cancer associated with a polymorphism in ARLTS1

Calin, G. A., Trapasso, F., Shimizu, M., Dumitru, C. D., Yendamuri, S., Godwin, A. K., Ferracin, M., Bernardi, G., Chatterjee, D., Baldassarre, G., Rattan, S., Alder, H., Mabuchi, H., Shiraishi, T., Hansen, L. L., Overgaard, J., Herlea, V., Mauro, F. R., Dighiero, G., Movsas, B., Rassenti, L., Kipps, T., Baffa, R., Fusco, A., Mori, M., Russo, G., Liu, C-G., Neuberg, D., Bullrich, F., Negrini, M. & Croce, C. M., 21 apr. 2005, I : The New England Journal of Medicine. 352, 16, s. 1667-76 10 s.

Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor

Bentzen, L., Vestergaard-Poulsen, P., Nielsen, T., Overgaard, J., Bjørnerud, A., Briley-Saebø, K., Horsman, M. R. & Østergaard, L., 15 mar. 2005, I : International Journal of Radiation Oncology, Biology, Physics. 61, 4, s. 1208-15 8 s.

The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study

Eriksen, J. G., Steiniche, T., Overgaard, J. & Danish Head and Neck Cancer Study Group (DAHANCA), feb. 2005, I : Radiotherapy & Oncology. 74, 2, s. 93-100 8 s.

TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer

Andreassen, C. N., Alsner, J., Overgaard, J., Herskind, C., Haviland, J., Owen, R., Homewood, J., Bliss, J. & Yarnold, J., 2005, I : Radiotherapy & Oncology. 75, 1, s. 18-21 4 s.

Application of microarray analyses to identify genes involved in radiation-induced fibrosis (RIF)

Rødningen, O. K., Alsner, J., Hastie, T., Overgaard, J. & Børresen-Dale, A-L., 2005, Breast Cancer Res.. 7(Suppl 2) udg. s. S42-S43

Influence of oxygen concentration and pH on expression of hypoxia induced genes

Sørensen, B. S., Hao, J., Overgaard, J., Alsner, J. & Horsman, M. R., 2005, Proceedings of the 9th International Wolfsberg Meeting on Molecular Radiation Biology / Oncology. 6 udg. s. 75 1 s.

Long-term anorectal dysfunction after postoperative radiotehrapy for rectal cancer

Lundby, L., Krogh, K., Jensen, VJ., Gandrup, P., Qvist, N., Overgaard, J. & Laurberg, S., 2005, I : Dis Colon & Rectum. 48, 7, s. 1343-9

Long-term anorectal dysfunction after postoperative radiotherapy for rectal cancer

Lundby, L., Krogh, K., Jensen, V. J., Gandrup, P., Qvist, N., Overgaard, J. & Laurberg, S., 2005, I : Dis Colon & Rectum. 48, 7, s. 1343-1349 7 s.

Radiotherapy and Oncology comes of age

Overgaard, J., 2005, I : Radiotherapy & Oncology. 75, 1, s. 1-5

Survival after enucleation and radiation brachy therapy for choroidal and ciliary body melanomas

Isager, P., Ehlers, N. & Overgaard, J., 2005, I : Acta Ophthalmologica. 83, 3, s. 398

The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study.

Eriksen, J. G., Steiniche, T. & Overgaard, J., 2005, I : Radiother. Oncol.. 74, 2, s. 93-100

The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma

Eriksen, J. G., Steiniche, T. & Overgaard, J., 2005, I : Acta. Oncol.. 44, 1, s. 50-58 9 s.

Have choroidal and ciliary body melanomas changed during the period 1955-2000?

Isager, P., Ehlers, N. & Overgaard, J., okt. 2004, I : Acta Ophthalmologica. 82, 5, s. 509-516 8 s.

Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas

Isager, P., Ehlers, N. & Overgaard, J., okt. 2004, I : Acta Ophthalmologica. 82, 5, s. 517-525 9 s.

Expression of integrins and E-cadherin in squamous cell carcinomas of the head and neck

Eriksen, J. G., Steiniche, T., Søgaard, H. & Overgaard, J., sep. 2004, I : Acta Pathologica Microbiologica et Immunologica Scandinavica. 112, 9, s. 560-568 9 s.

Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas

Eriksen, J. G., Buffa, F. M., Alsner, J., Steiniche, T., Bentzen, S. M. & Overgaard, J., sep. 2004, I : Radiotherapy & Oncology. 72, 3, s. 275-282 8 s.

Optimisation and validation of methods to assess single nucleotide polymorphisms (SNPs) in archival histological material

Andreassen, C. N., Sørensen, F. B., Overgaard, J. & Alsner, J., sep. 2004, I : Radiotherapy & Oncology. 72, 3, s. 351-356 6 s.

Tumour burden and interleukin-2 dose affect the interaction between low-dose total body irradiation and interleukin 2

Safwat, A. A., Aggerholm-Pedersen, N., Roitt, I., Overgaard, J. & Hokland, M., jun. 2004, I : European Journal of Cancer. 40, 9, s. 1412-1417 6 s.

Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen

Horsman, M. R. & Overgaard, J., mar. 2004, I : Radiotherapy & Oncology. 70, 3, s. 301-309 9 s.

The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck

Eriksen, J. G., Steiniche, T., Askaa, J., Alsner, J. & Overgaard, J., 1 feb. 2004, I : International Journal of Radiation Oncology, Biology, Physics. 58, 2, s. 561-566 6 s.

For X-irradiated normal human fibroblasts, only half of cell inactivation results from chromosomal damage

Borgmann, K., Dede, M., Wrona, A., Brammer, I., Overgaard, J. & Dikomey, E., feb. 2004, I : International Journal of Radiation Oncology, Biology, Physics. 58, 2, s. 445-452 8 s.

Nodal control and surgical salvage after primary radiotherapy in 1782 patients with laryngeal and pharyngeal carcinoma

Johansen, L. V., Grau, C. & Overgaard, J., 1 jan. 2004, I : Acta Oncologica. 43, 5, s. 486-94 9 s.

Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes

Olsen, K. E., Knudsen, H., Rasmussen, B. B., Balslev, E., Knoop, A., Ejlertsen, B., Nielsen, K. V., Schönau, A. & Overgaard, J., 2004, I : Acta Oncologica. 43, 1, s. 35-42 8 s.

Does stage at diagnosis explain the difference in survival after breast cancer in Denmark and Sweden?

Jensen, A. R., Garne, J. P., Storm, H. H., Engholm, G., Möller, T. & Overgaard, J., 2004, I : Acta Oncologica. 43, 8, s. 719-26 8 s.

Early and late treatment-related morbidity following radical cystectomy

Knap, M., Lundbeck, F. & Overgaard, J., 2004, I : Scandinavian Journal of Urology and Nephrology. 38, s. 145-152 8 s.

Quantitative PCR - new diagnostic tool for quantifying specific mRNA and DNA molecules: HER2/neu DNA quantification with LightCycler real-time PCR in comparison with immunohistochemistry and fluorescence in situhybridization

Schlemmer, B. O., Sørensen, B. S., Overgaard, J., Olsen, K. E., Gjerdrum, L. M. & Nexø, E., 2004, I : Scandinavian Journal of Clinical & Laboratory Investigation. 64, 5, s. 511-522 12 s.

Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer

Nordsmark, M. & Overgaard, J., 2004, I : Acta Oncologica. 43, 4, s. 396-403 8 s.

The prognostic relevance of estimates of proliferative activity in early breast cancer

Offersen, B. V., Sørensen, F. B., Knoop, A. & Overgaard, J., dec. 2003, I : Histopathology. 43, 6, s. 573-582 10 s.

Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes

Andreassen, C. N., Alsner, J., Overgaard, M. & Overgaard, J., nov. 2003, I : Radiotherapy & Oncology. 69, 2, s. 127-135 9 s.

Prediction of radiotherapy complications from polymorphisms in candidate genes

Andreassen, C. N., Alsner, J., Overgaard, M. & Overgaard, J., nov. 2003, I : Radiotherapy & Oncology. 69, 2, s. 127-135 9 s.

The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas

Offersen, B. V., Nielsen, B. S., Høyer-Hansen, G., Rank, F., Hamilton-Dutoit, S., Overgaard, J. & Andreasen, P. A., nov. 2003, I : American Journal of Pathology. 163, 5, s. 1887-1899 13 s.

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial

Overgaard, J., Hansen, H. S., Specht, L., Overgaard, M., Grau, C., Andersen, E. V., Bentzen, J. K. D., Bastholt, L., Hansen, O., Johansen, J., Andersen, L. & Evensen, J. F., 20 sep. 2003, I : Lancet. 362, 9388, s. 933-40 8 s.

Low-dose total body irradiation augments the therapeutic effect of Interleukin-2 in a mouse model for metastatic malignant melanoma

Safwat, A. A., Aggerholm, N., Roitt, I., Overgaard, J. & Hokland, M., aug. 2003, I : Journal of Experimental Therapeutics and Oncology. 3, 4, s. 161-168 8 s.

Time trends and regional differences in registration, stage distribution, surgical management and surrival of breast cancer in Denmark

Jensen, A. R., Ewertz, M., Cold, S., Storm, H. H. & Overgaard, J., aug. 2003, I : European Journal of Cancer. 39, 12, s. 1783-1793 11 s.

Does amifostine have a role in chemoradiation treatment?

Brizel, D. M. & Overgaard, J., jun. 2003, I : Lancet Oncology. 4, 6, s. 378-81 4 s.

Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research

Celis, J. E., Gromov, P., Gromova, I., Moreira, J. M. A., Cabezón, T., Ambartsumian, N., Grigorian, M., Lukanidin, E., thor Straten, E. P., Guldberg, P., Bartkova, J., Bartek, J., Lukas, J., Lukas, C., Lykkesfeldt, A., Jäättelä, M., Roepstorff, P., Bolund, L., Ørntoft, T. F., Brünner, N., Overgaard, J., Sandelin, K., Blichert-Toft, M., Mouridsen, H. & Rank, F., jun. 2003, I : Molecular and Cellular Proteomics. 2, 6, s. 369-77 9 s.

Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours

Bentzen, L. N., Keiding, S., Nordsmark, M., Falborg, L., Hansen, S. B., Keller, J. Ø., Nielsen, O. S. & Overgaard, J., jun. 2003, I : Radiotherapy & Oncology. 67, 3, s. 339-44 6 s.

Tumour oxygenation assessed by F-18-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours

Bentzen, L., Keiding, S., Nordsmark, M., Falborg, L., Hansen, SB., Keller, J., Nielsen, OS. & Overgaard, J., jun. 2003, I : Radiotherapy & Oncology. 67, 3, s. 339-344 6 s.

Quantification of angiogenesis as a prognostic marker in human carcinomas: acritical evaluation of histopathological methods for estimation of vascular density

Offersen, B. V., Borre, M. & Overgaard, J., maj 2003, I : European Journal of Cancer. 39, 7, s. 881-890 10 s.

Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial

Grau, C., Prakash Agarwal, J., Jabeen, K., Rab Khan, A., Abeyakoon, S., Hadjieva, T., Wahid, I., Turkan, S., Tatsuzaki, H., Dinshaw, K. A. & Overgaard, J., 1 apr. 2003, I : Radiotherapy & Oncology. 67, 1, s. 17-26 10 s.

Measurements of hypoxia using pimonidazole and polarograhpic oxygen-sensitive electrodes in human cervix carcinomas

Nordsmark, M., Loncaster, J., Aquino-Parsons, C., Chou, S-C., Ladekarl, M., Havsteen, H., Lindegaard, J. C., Davidson, S. E., Varia, M., West, C., Hunter, R., Overgaard, J. & Raleigh, J. A., apr. 2003, I : Radiotherapy & Oncology. 67, 1, s. 35-44 10 s.

The role of pelvic lymph node dissection as a predictive and prognostic factor in bladder cancer

Knap, M., Lundbeck, F. & Overgaard, J., mar. 2003, I : European Journal of Cancer. 39, 5, s. 604-613 10 s.

Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients

Hansen, S., Overgaard, J., Rose, C., Knoop, A., Lænkholm, A-V., Andersen, J., Sørensen, F. B. & Andreasen, P., 13 jan. 2003, I : B J C. 88, 1, s. 102-108 7 s.

Evaluation of objective measures of smoking status--a prospective clinical study in a group of head and neck cancer patients treated with radiotherapy

Hald, J., Overgaard, J. & Grau, C., 1 jan. 2003, I : Acta Oncologica. 42, 2, s. 154-9 6 s.

Clinical trials are key to progress

Overgaard, J., 2003, I : European Journal of Cancer. 39, 2, s. 133 1 s.

Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research

Celis, J. E., Gromov, P., Gromova, I., Moreira, J. M., Gabezon, T., Ambartsumian, N., Grigorian, M., Lukanidin, E., Thor Straten, P., Guldberg, P., Bartkova, J., Bartek, J., Lukas, J., Lukas, C., Lykkesfeldt, A., Jaattela, M., Roepstorff, P., Bolund, L., Ørntoft, T. F., Brunner, N., Overgaard, J., Sandelin, K., Blicht-Toft, M., Mouridsen, H. & Rank, F. E., 2003, I : Mol. Cell. Proteomics. 2, 6, s. 369-377 9 s.

Laryngeal carcinoma--multivariate analysis of prognostic factors in 1252 consecutive patients treated with primary radiotherapy

Johansen, L. V., Grau, C. & Overgaard, J., 2003, I : Acta Oncologica. 42, 7, s. 771-8 8 s.

Prognostic factors, pattern of recurrence and survival in a Danish bladder cancer cohort treated with radical cystectomy

Knap, M., Lundbeck, F. & Overgaard, J., 2003, I : Acta Oncologica. 42, 2, s. 160-168 9 s.

Salvage laryngectomy and pharyngocutaneous fistulae after primary radiotherapy for head and neck cancer: a national survey from DAHANCA

Grau, C., Johansen, L. V., Hansen, H. S., Andersen, E. V., Godballe, C., Andersen, L. J., Hald, J., Møller, H., Overgaard, M., Bastholt, L., Greisen, O., Harbo, G., Hansen, O. & Overgaard, J., 2003, I : Head & Neck (Print Edition). 25, 9, s. 711-6 6 s.

Stage and survival in breast cancer patients in screened and non-screened Danish and Swedish populations

Jensen, A. R., Garne, J. P., Storm, H. H., Ewertz, M., Cold, S., Alvegaard, T. & Overgaard, J., 2003, I : Acta Oncologica. 42, 7, s. 701-709 9 s.

Stage and survival in breast cancer patients in screened and non-screened Danish and Swedish populations.

Jensen, A. R., Garne, J. P., Storm, H. H., Ewertz, M., Cold, S., Alvegaard, T. & Overgaard, J., 2003, I : Acta Oncologica. 42, 7, s. 701-9 8 s.

Validity and representativity in the Danish Breast Cancer Cooperative Group--a study on protocol allocation and data validity from one county to a multi-centre database

Jensen, A. R., Storm, H. H., Møller, S. & Overgaard, J., 2003, I : Acta Oncologica. 42, 3, s. 179-85 7 s.

Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis

Offersen, B. V., Knap, M., Marcussen, N., Horsman, M. R., Hamilton-Dutoit, S. J. & Overgaard, J., 2 dec. 2002, I : British Journal of Cancer. 87, 12, s. 1422-1430 9 s.

Prognostic indicators for malignant tumours of the parotid gland

Harbo, G., Bundgaard, T., Pedersen, D., Søgaard, H. & Overgaard, J., dec. 2002, I : Clinical Otolaryngology. 27, 6, s. 512-516 5 s.

Allelic imbalance in selected chromosomal regions in ovarian cancer

Hansen, L. L., Jensen, L. L., Dimitrakakis, C., Michalas, S., Gilbert, F., Barber, H. R. K., Overgaard, J. & Arzimanoglou, L. I., nov. 2002, I : Cancer Genetics and Cytogenetics. 139, 1, s. 1-8 9 s.

Expert reviews, systematic reviews and meta-analyses

Macbeth, F. & Overgaard, J., sep. 2002, I : Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 64, 3, s. 233-234 2 s.

Comparison of two T-classification systems for sino-nasal carcinoma

Andersen, G. H., Bundgaard, T., Overgaard, J. & Grau, C., 1 aug. 2002, I : Clinical Otolaryngology. 27, 4, s. 254-9 6 s.

Does variability in normal tissue reactions after radiotherapy have a genetic basis - where and how to look for it

Andreassen, C. N., Alsner, J. & Overgaard, J., aug. 2002, I : Radiotherapy & Oncology. 64, 2, s. 131-140 10 s.

Validity of breast cancer in the Danish Cancer Registry: A study based on clinical records from one county in Denmark

Jensen, A. R., Overgaard, J. & Storm, H. H., aug. 2002, I : European Journal of Cancer Prevention. 11, 4, s. 359-364 6 s.

Supraglottic carcinoma: patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients

Johansen, L. V., Grau, C. & Overgaard, J., 15 jul. 2002, I : International Journal of Radiation Oncology, Biology, Physics. 53, 4, s. 948-58 11 s.

Early and late effects of irradiation on morphometry and residual strain of mouse rectum

Gregersen, H., Lundby, L. & Overgaard, J., jul. 2002, I : Digestive Diseases and Sciences. 47, 7, s. 1472-1479 8 s.

Glottic carcinoma--patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients

Johansen, L. V., Grau, C. & Overgaard, J., 1 jun. 2002, I : Radiotherapy & Oncology. 63, 3, s. 257-67 11 s.

Comparison of methods of microvascular staining and quantification in prostate carcinoma: Relevance to Prognosis

Offersen, B. V., Borre, M., Sørensen, F. B. & Overgaard, J., feb. 2002, I : Acta Pathologica Microbiologica et Immunologica Scandinavica. 110, 2, s. 177-185 9 s.

Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer

Holten-Andersen, M. N., Christensen, I. J., Nielsen, H. J., Stephens, R. W., Jensen, V., Nielsen, O. H., Sørensen, S., Overgaard, J., Lilja, H., Harris, A., Murphy, G. & Brünner, N., jan. 2002, I : Clinical Cancer Research. 8, 1, s. 156-164 9 s.

Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volumes and carbogen breathing

Bentzen, L. N., Keiding, S., Horsman, M. R., Grönroos, T., Hansen, S. B. & Overgaard, J., 2002, I : Acta Oncologica. 41, 3, s. 304-312 9 s.

Chalkley estimates of angiogenesis in early breast cancer--relevance to prognosis

Offersen, B. V., Sørensen, F. B., Yilmaz, M., Knoop, A., Overgaard, J. & Committee, D. B. C. C. G. T. B., 2002, I : Acta Oncologica. 41, 7-8, s. 695-703 9 s.

Comparison of methods of microvascular staining and quantification in prostate carcinoma: Relevance to prognosis

Offersen, B. V., Borre, M., Sørensen, FB. & Overgaard, J., 2002, I : Acta Pathologica Microbiologica et Immunologica Scandinavica. 110, s. 177-85

Comparison of methods of microvascular staining and quantification in prostate carcinoma: relevance to prognosis

Offersen, B. V., Borre, M., Sørensen, F. B. & Overgaard, J., 2002, I : Acta Pathologica Microbiologica et Immunologica Scandinavica. 110, 2, s. 177-85 8 s.

Cosmetic outcome and breast morbidity in breast-concerving treatment: results from the Danish DBCG-82TM ational randomized trial in breast cancer

Johansen, J., Overgaard, J., Rose, C., Engelholm, S. A., Gadeberg, C. C., Kjær, M., Kamby, C., Christensen, J. J., Blichert-Toft, M. & Overgaard, M., 2002, I : Acta Oncologica. 41, 4, s. 369-380 12 s.

Impact of delay on diagnosis and treatment of primary lung cancer

Jensen, A. R., Mainz, J. & Overgaard, J., 2002, I : Acta Oncologica. 41, 2, s. 147-152 6 s.

Sigvard Kaae - in memoriam

Johansen, H., Overgaard, J. & Sell, A., 2002, I : Ugeskrift for Laeger. 164, 1, s. 95-96 2 s.

Combretastatin A-4 disodium phosphate: a vascular targeting agent that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotherapy

Murata, R., Overgaard, J. & Horsman, M. R., 15 nov. 2001, I : International Journal of Radiation Oncology, Biology, Physics. 51, 4, s. 1018-1024 7 s.

Improved tumor response by combining radiation and the vascular-damaging drug 5,6-dimethylxanthenone-4-acetic acid

Murata, R., Siemann, D. W., Overgaard, J. & Horsman, M. R., nov. 2001, I : Radiation Research. 156, 5 pt 1, s. 503-509 7 s.

Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid

Murata, R., Overgaard, J. & Horsman, M. R., nov. 2001, I : International Journal of Hyperthermia. 17, 6, s. 508-519 12 s.

Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors

Murata, R., Siemann, D. W., Overgaard, J. & Horsman, M. R., aug. 2001, I : Radiotherapy & Oncology. 60, 2, s. 155-161 7 s.

Effect of changing tumor oxygenation on glycolytic metabolism in a murine C3H mammary carcinoma assessed by in vivo nuclear magnetic resonance spectroscopy

Nielsen, F. U., Daugård, P., Bentzen, L. N., Overgaard, J., Stødkilde-Jørgensen, H., Horsman, M. R. & Maxwell, R. J., 1 jul. 2001, I : Cancer Research. 61, 13, s. 5318-25 8 s.

TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck

Alsner, J., Sørensen, S. B. & Overgaard, J., maj 2001, I : Radiotherapy & Oncology. 59, 2, s. 179-185 7 s.

Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations

Nordsmark, M., Alsner, J., Keller, J. Ø., Nielsen, O. S., Jensen, O. M. & Overgaard, J., 20 apr. 2001, I : British Journal of Cancer. 84, 8, s. 1070-1075 6 s.

Patterns of angiogenesis in nonsmall-cell lung carcinoma

Offersen, B. V., Pfeiffer, P., Hamilton-Dutoit, S. & Overgaard, J., 15 apr. 2001, I : Cancer. 91, 8, s. 1500-1509 10 s.

Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck

Alsner, J., Høyer, M., Sørensen, S. B. & Overgaard, J., 1 feb. 2001, I : International Journal of Radiation Oncology, Biology, Physics. 49, 2, s. 519-525 7 s.

Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma

Nordsmark, M., Loncaster, J., Chou, C. G. H., Havsteen, H., Lindegaard, J. C., Davidson, S. E., Varia, M., West, C., Hunter, R., Overgaard, J. & Raleigh, J. A., 1 feb. 2001, I : International Journal of Radiation Oncology, Biology, Physics. 49, 2, s. 581-6 6 s.

Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues

Murata, R., Overgaard, J. & Horsman, M. R., feb. 2001, I : International Journal of Radiation Biology. 77, 2, s. 195-204 10 s.

Squamous cell carcinoma of the nasopharynx--an analysis of treatment results in 149 consecutive patients

Johansen, L. V., Grau, C. & Overgaard, J., 1 jan. 2001, I : Acta Oncologica. 40, 7, s. 801-9 9 s.

A future for hyperthermia in cancer treatment?

Nielsen, O. S., Horsman, M. R. & Overgaard, J., 2001, I : European Journal of Cancer. 37, 13, s. 1587-9 3 s.

Effect of changing tumor oxygenation on glycolytic metabolism in a murine C3H mammary carcinoma assessed by in vivo Nuclear Magnetic Resonance spectroscopy

Nielsen, F. U., Christensen, P. D., Overgaard, J., Stødkilde-Jørgensen, H., Horsman, M. R. & Maxwell, R. J., 2001, I : Cancer Res.. 61, 13, s. 5318-5325 8 s.

Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiation

Horsman, M. R., Murata, R. & Overgaard, J., 2001, I : Acta Oncologica. 40, 4, s. 497-503 7 s.

Patterns of angiogenesis in nonsmall-cell lung carcinoma

Offersen, B. V., Pfeiffer, P., Hamilton-Dutoit, S. & Overgaard, J., 2001, I : Cancer. 91, 8, s. 1500-9 9 s.

A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy

Nordsmark, M. & Overgaard, J., okt. 2000, I : Radiotherapy & Oncology. 57, 1, s. 39-43 5 s.

Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients

Alsner, J., Yilmaz, M., Guldberg, P., Hansen, L. L. & Overgaard, J., okt. 2000, I : Clinical Cancer Research. 6, 10, s. 3923-31 9 s.

A tribute to the founding editor

Overgaard, J., 1 jun. 2000, I : Radiotherapy & Oncology. 55, 3, s. 203-4 2 s.

Histopathological and morphometric analyses of late rectal injury after irradiation

Lundby, L., Overgaard, J. & Laurberg, S., mar. 2000, I : A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica. 108, 3, s. 216-22 7 s.

Relationship between DNA double-strand breaks, cell killing, and fibrosis studied in confluent skin fibroblasts derived from breast cancer patients

Dikomey, E., Brammer, I., Johansen, J., Bentzen, S. M. & Overgaard, J., 15 jan. 2000, I : International Journal of Radiation Oncology, Biology, Physics. 46, 2, s. 481-90 10 s.

Hypopharyngeal squamous cell carcinoma--treatment results in 138 consecutively admitted patients

Johansen, L. V., Grau, C. & Overgaard, J., 1 jan. 2000, I : Acta Oncologica. 39, 4, s. 529-36 8 s.

Squamous cell carcinoma of the oropharynx--an analysis of treatment results in 289 consecutive patients

Johansen, L. V., Grau, C. & Overgaard, J., 1 jan. 2000, I : Acta Oncologica. 39, 8, s. 985-94 10 s.

TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer

Overgaard, J., Yilmaz, M., Guldberg, P., Hansen, L. L. & Alsner, J., 2000, I : Acta oncologica (Stockholm, Sweden). 39, 3, s. 327-33 7 s.

Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrinedifferentiated tumor cells and outcome in prostate cancer patients subjected to watchful waiting

Borre, M., Nerstrøm, B. & Overgaard, J., 2000, I : Clinical Cancer Research. 6, s. 1882-90

Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucose

Bentzen, L. N., Keiding, S., Horsman, M. R., Falborg, L., Hansen, S. B. & Overgaard, J., 2000, I : Acta Oncologica. 39, 5, s. 629-37 9 s.

Fibroblast differentiation in subcutaneous fibrosis after postmastectomy radiotherapy

Herskind, C., Johansen, J., Bentzen, S. M., Overgaard, M., Overgaard, J., Bamberg, M. & Rodemann, H. P., 2000, I : Acta Oncologica. 39, 3, s. 383-8 6 s.

Importance of overall treatment time for the response to radiotherapy in patients with squamous cell carcinoma of the head and neck

Overgaard, J., Alsner, J., Eriksen, J., Horsman, M. R. & Grau, C., 2000, I : Rays. 25, 3, s. 313-9 7 s.

Late treatment-related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone

Højris, I., Andersen, J., Overgaard, M. & Overgaard, J., 2000, I : Acta Oncologica. 39, 3, s. 355-72 18 s.

Management of the axilla in breast cancer. Implication for diagnosis, prognosis, treatment, and morbidity

Overgaard, J., 2000, I : Acta Oncologica. 39, 3, s. 259-260 2 s.

Risk factors of arm lymphedema in breast cancer patients

Kocak, Z. & Overgaard, J., 2000, I : Acta oncologica (Stockholm, Sweden). 39, 3, s. 389-92 4 s.

Time course of radiological lung density changes after postmastectomy radiotherapy

Skoczylas, J. Z., Bentzen, S. M., Overgaard, M. & Overgaard, J., 2000, I : Acta Oncologica. 39, 2, s. 181-7 7 s.

Time-course of the hazard of murine nephropathy induced by total-body irradiation

Safwat, A., Bentzen, S., Nielsen, O. S. & Overgaard, J., 2000, I : International Journal of Radiation Biology. 76, 7, s. 979-83 5 s.

Treatment of morbidity associated with the management of the axilla in breast-conserving therapy

Johansen, J., Overgaard, J., Blichert-Toft, M. & Overgaard, M., 2000, I : Acta Oncologica. 39, 3, s. 349-54 6 s.

p53 accumulation associated with bcl-2 and MIB-1, and survival in prostate cancer patients subjected to watchful waiting

Borre, M., Borre, M., Stausbøl-Grøn, B., Nerstrøm, B. & Overgaard, J., 2000, I : The Journal of Urology. 164, s. 716-21

The effect of castration on tumour growth rate and cell kinetics in hormone-sensitive and hormone-insensitive rat prostatic adenomas

Nerstrøm Salling, L., Høyer, M. & Overgaard, J., nov. 1999, I : Urologic Oncology: Seminars and Original Investigations. 2, S3, s. S29 1 s.

Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group

Højris, I., Overgaard, M., Christensen, J. J. & Overgaard, J., 23 okt. 1999, I : Lancet. 354, 9188, s. 1425-30 6 s.

Localized in vivo 1H NMR spectroscopy of murine tumours: Effect of blood flow reduction

Nielsen, F. U., Topp, S-K., Horsman, M. R., Overgaard, J., Stødkilde-Jørgensen, H. & Maxwell, R. J., jun. 1999, I : NMR in Biomedicine. 12, 4, s. 175-83 9 s.

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial

Overgaard, M., Jensen, M-B., Overgaard, J., Hansen, P. S., Rose, C., Andersson, M., Kamby, C., Kjaer, M., Gadeberg, C., Rasmussen, B. B., Blichert-Toft, M. & Mouridsen, H. T., 15 maj 1999, I : Lancet. 353, 9165, s. 1641-8 8 s.

In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data

Stausbøl-Grøn, B., Bentzen, S. M., Jørgensen, K. E., Nielsen, O. S., Bundgaard, T. & Overgaard, J., mar. 1999, I : British Journal of Cancer. 79, 7-8, s. 1074-84 11 s.

Ku70/80 gene expression and DNA-dependent protein kinase (DNA-PK) activity do not correlate with double-strand break (dsb) repair capacity and cellular radiosensitivity in normal human fibroblasts

Kasten, U., Plottner, N., Johansen, J., Overgaard, J. & Dikomey, E., mar. 1999, I : B J C. 79, 7-8, s. 1037-41 5 s.

The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis

Begg, A. C., Haustermans, K., Hart, A. A., Dische, S., Saunders, M., Zackrisson, B., Gustaffson, H., Coucke, P., Paschoud, N., Høyer, M., Overgaard, J., Antognoni, P., Richetti, A., Bourhis, J., Bartelink, H., Horiot, J. C., Corvo, R., Giaretti, W., Awwad, H., Shouman, T., Jouffroy, T., Maciorowski, Z., Dobrowsky, W., Struikmans, H. & Wilson, G. D., jan. 1999, I : Radiotherapy & Oncology. 50, 1, s. 13-23 11 s.

Angiogenesis - a prognostic marker for prostate cancer

Borre, M., Offersen, B. V., Nerstrøm, B. & Overgaard, J., 1999, I : Ugeskrift for Laeger. 25, s. 3832-36

Techniques to assess the oxygenation of human tumors. State of the art

Horsman, M. R., Nordsmark, M. & Overgaard, J., dec. 1998, I : Strahlentherapie und Onkologie. 174 , Suppl 4, s. 2-5 4 s.

The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors

Horsman, M. R., Ehrnrooth, E., Ladekarl, M. & Overgaard, J., 1 nov. 1998, I : International Journal of Radiation Oncology, Biology, Physics. 42, 4, s. 895-898 4 s.

DNA ploidy and survival of patients with clinically localized prostate cancer treated without intent to cure

Borre, M., Høyer, M., Nerstrøm, B. & Overgaard, J., 1 sep. 1998, I : Prostate. 36, 4, s. 244-249 6 s.

Fibroblast growth in the soft agar clonogenic assay for cervix cancer radiosensitivity

Stausbøl-Grøn, B., Havsteen, H. & Overgaard, J., aug. 1998, I : B J C. 78, 4, s. 550-3 4 s.

Radiosensitivity of normal fibroblasts from breast cancer patients assessed by the micronucleus and colony assays

Johansen, J., Streffer, C., Fuhrmann, C., Bentzen, S. M., Stausbøl-Grøn, B., Overgaard, M. & Overgaard, J., jun. 1998, I : International Journal of Radiation Biology. 73, 6, s. 671-8 8 s.

Tumor cell proliferation and survival in patients with prostate cancer followed expectantly

Borre, M., Bentzen, S. M., Nerstrøm, B. & Overgaard, J., maj 1998, I : Journal of Urology. 159, 5, s. 1609-14 6 s.

Association between in vivo iododeoxyuridine labeling, MIB-1 expression, malignancy grade and clinical stage in human prostate cancer

Borre, M., Høyer, M., Sørensen, F. B., Nerstrøm, B. & Overgaard, J., mar. 1998, I : A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica. 106, 3, s. 389-395 7 s.

Association between in vivo iododeoxyuridine labeling, MIB-1 expression, malignancy grade and clinical stage in human prostate cancer

Borre, M., Høyer, M., Sørensen, F. B., Nerstrøm, B. & Overgaard, J., mar. 1998, I : APMIS Supplementum. 106, 3, s. 389-395 7 s.

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer

Knoop, A., Andreasen, P. A., Andersen, J. A., Hansen, S., Lænkholm, A-V., Simonsen, A. C. W., Andersen, J., Overgaard, J. & Rose, C., mar. 1998, I : B J C. 77, 6, s. 932-940 9 s.

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85

Overgaard, J., Hansen, H. S., Overgaard, M., Bastholt, L., Berthelsen, A., Specht, L., Lindeløv, B. & Jørgensen, K., feb. 1998, I : Radiotherapy & Oncology. 46, 2, s. 135-46 12 s.

Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck

Høyer, M., Jørgensen, K., Bundgaard, T., Johansen, L. V., Bentzen, S. M., Overgaard, M., Hansen, O., Søgaard, H. & Overgaard, J., feb. 1998, I : Radiotherapy & Oncology. 46, 2, s. 147-155 9 s.

Evidence based radiation oncology

Overgaard, J. & Bentzen, S. M., jan. 1998, I : Radiotherapy & Oncology. 46, 1, s. 1-3 3 s.

Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer

Hansen, L. L., Yilmaz, M., Overgaard, J., Andersen, J. & Kruse, T. A., 1998, I : Cancer Research. 58, 10, s. 2166-9 4 s.

Association between in vivo iododeoxyuridine labelling, MIB-1 expression, malignancy grade and clinical stage in human prostate cancer

Borre, M., Høyer, M., Sørensen, F. B., Nerstrøm, B. & Overgaard, J., 1998, I : Acta Pathologica Microbiologica et Immunologica Scandinavica. 106, s. 389-95

Characterization and radiosensitivity of fibroblasts derived from squamous cell carcinomas of the head and neck, and the surrounding oral mucosa

Stausbøl-Grøn, B., Bentzen, S. M. & Overgaard, J., 1998, I : Acta Oncologica. 37, 7-8, s. 697-700 4 s.

Deoxyribonucleic acid ploidy and survival in clinically localized prostate cancer patients treated without intent to cure

Borre, M., Høyer, M., Nerstrøm, B. & Overgaard, J., 1998, I : Prostate. 36, s. 244-9

Immunohistochemical BCL-2 and Ki-67 expression predict survival in prostate cancer patients followed expectantly

Borre, M., Stausbøl-Grøn, B., Nerstrøm, B. & Overgaard, J., 1998, I : Prostate Cancer and Prostatic Diseases. 5, s. 268-75

Immunohistochemical determination of tumour angiogenesis measured in the maximal microvessel density in human prostate cancer

Offersen, B. V., Borre, M. & Overgaard, J., 1998, I : Acta Pathologica Microbiologica et Immunologica Scandinavica. 106, s. 463-9

Mcrovessel density predicts survival in prostate cancer patients subjected to watchful waiting

Borre, M., Offersen, B. V., Nerstrøm, B. & Overgaard, J., 1998, I : British Journal of Cancer. 78, s. 940-4

Molecular genetic analysis of easily accessible breast tumour DNA, purified from tissue left over from hormone receptor measurement

Hansen, L. L., Andersen, J., Overgaard, J. & Kruse, T. A., 1998, I : Acta Pathologica Microbiologica et Immunologica Scandinavica. 106, 3, s. 371-7 7 s.

The effect of shark cartilage extracts on the growth and metastatic spread of the SCCVII carcinoma

Horsman, M. R., Alsner, J. & Overgaard, J., 1998, I : Acta Oncologica. 37, 5, s. 441-5 5 s.

Tumour cell proliferation and survival of patients with prostate cancer followed expectantly

Borre, M., Bentzen, SM., Nerstrøm, B. & Overgaard, J., 1998, I : The Journal of Urology. s. 1609-14

Steepness of the dose-response curve as a function of volume in an experimental tumor irradiated under ambient or hypoxic conditions

Khalil, A. A., Bentzen, S. M. & Overgaard, J., 1 nov. 1997, I : International Journal of Radiation Oncology, Biology, Physics. 39, 4, s. 797-802 6 s.

Nicotinamide as a radiosensitizer in tumours and normal tissues: the importance of drug dose and timing

Horsman, M. R., Siemann, D. W., Chaplin, D. J. & Overgaard, J., nov. 1997, I : Radiotherapy & Oncology. 45, 2, s. 167-74 8 s.

Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation

Hansen, O., Overgaard, J., Hansen, H. S., Overgaard, M., Høyer, M., Jørgensen, K. E., Bastholt, L. & Berthelsen, A., apr. 1997, I : Radiotherapy & Oncology. 43, 1, s. 47-51 5 s.

Centraliseret efterkontrol af patienter behandlet for hoved-halskraeft

Grau, C., Specht, L. K., Hansen, H. S., Overgaard, M. & Overgaard, J., 17 feb. 1997, I : Ugeskrift for Laeger. 159, 8, s. 1104-8 5 s.

Cancer of the nasal cavity and paranasal sinuses. A clinico-pathological study of 277 patients

Harbo, G., Grau, C., Bundgaard, T., Overgaard, M., Elbrønd, O., Søgaard, H. & Overgaard, J., 1 jan. 1997, I : Acta Oncologica. 36, 1, s. 45-50 6 s.

Detection of hypoxic cells in a C3H mouse mammary carcinoma using the comet assay

Olive, P. L., Horsman, M. R., Grau, C. & Overgaard, J., 1 jan. 1997, I : British Journal of Cancer. 76, 6, s. 694-9 6 s.

Epidermal growth factor and acute radiation damage in CDF1 mice in vivo

Lindegaard, J. C., Vinter-Jensen, L. & Overgaard, J., 1 jan. 1997, I : Acta Oncologica. 36, 4, s. 393-6 4 s.

Can mild hyperthermia improve tumour oxygenation?

Horsman, M. R. & Overgaard, J., 1997, I : International Journal of Hyperthermia. 13, 2, s. 141-7 7 s.

Prostate cancer an expensive dilemma

Borre, M., Nerstrøm, B. & Overgaard, J., 1997, I : Ugeskrift for Laeger. 17, s. 2534-37

Tumour oxygenation assessed by polarographic needle electrodes and bioenergetic status measured by 31 p magnetic resonanse spectroscopy in human soft tissue tumours

Nordsmark, M., Keller, J. Ø., Nielsen, O. S., Lunddorf, E. & Overgaard, J., 1997, I : Acta Oncologica. 36, 6, s. 565-571 7 s.

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

Nordsmark, M., Overgaard, M. & Overgaard, J., okt. 1996, I : Radiotherapy & Oncology. 41, 1, s. 31-9 9 s.

Postirradiation sensorineural hearing loss: a common but ignored late radiation complication

Grau, C. & Overgaard, J., 1 sep. 1996, I : International Journal of Radiation Oncology, Biology, Physics. 36, 2, s. 515-7 3 s.

Repair capacity of mouse lung after total body irradiation alone or combined with cyclophosphamide

Safwat, A., Bentzen, S. M., Nielsen, O. S., Mahmoud, H. K. & Overgaard, J., sep. 1996, I : Radiotherapy & Oncology. 40, 3, s. 249-257 9 s.

Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy

Johansen, J., Bentzen, S. M., Overgaard, J. & Overgaard, M., aug. 1996, I : Radiotherapy & Oncology. 40, 2, s. 101-9 9 s.

Uveal malignant melanoma. An ophthalmological or oncological disease?

Overgaard, J., aug. 1996, I : Acta Ophthalmologica. 74, 4, s. 313 1 s.

Radiotherapy-related lung fibrosis enhanced by tamoxifen

Bentzen, S. M., Skoczylas, J. Z., Overgaard, M. & Overgaard, J., 3 jul. 1996, I : National Cancer Institute. Journal (Print). 88, 13, s. 918-22 5 s.

The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas.

Nordsmark, M., Høyer, M., Keller, J. Ø., Nielsen, O. S., Jensen, O. M. & Overgaard, J., 1 jul. 1996, I : International Journal of Radiation Oncology, Biology, Physics. 35, 4, s. 701-708 8 s.

Effect of hydralazine in spontaneous tumours assessed by oxygen electrodes and 31P-magnetic resonance spectroscopy

Nordsmark, M., Maxwell, R. J., Wood, P. J., Stratford, I. J., Adams, G. E., Overgaard, J. & Horsman, M. R., jul. 1996, I : British Journal of Cancer. Supplement. 27, s. S232-S235 4 s.

Effect of nitro-L-arginine on blood flow, oxygenation and the activity of hypoxic cell cytotoxins in murine tumours

Horsman, M. R., Chaplin, D. J., Hill, S. A., Arnold, S., Collingridge, D., Radacic, M., Wood, P. J. & Overgaard, J., jul. 1996, I : British Journal of Cancer. Supplement. 27, s. S168-71 4 s.

Repopulation in the SCCVII squamous cell carcinoma assessed by an in vivo-in vitro excision assay

Hansen, O., Grau, C., Bentzen, S. M. & Overgaard, J., 1 maj 1996, I : Radiotherapy & Oncology. 39, 2, s. 137-44 8 s.

Growth of vestibular schwannomas: in situ model employing the monoclonal antibody Ki-67 and DNA flow cytometry

Charabi, S. A., Engel, P. J. H., Charabi, B. W., Jacobsen, G. K., Overgaard, J., Thomsen, J. & Tos, M., mar. 1996, I : The American journal of otology. 17, 2, s. 301-306 6 s.

Proliferative response of mouse spermatogonial stem cells after irradiation: a quantitative model analysis of experimental data

Judas, L., Bentzen, S. M., Hansen, P. V. & Overgaard, J., feb. 1996, I : Cell Proliferation. 29, 2, s. 73-87 15 s.

Quantitative assessment of radiation-induced lung changes by computerized optical densitometry of routine chest x-rays

Bentzen, S. M., Skoczylas, J. Z., Overgaard, M., Overgaard, J., Nielsen, O. G. & Madsen, E. H., 15 jan. 1996, I : International Journal of Radiation Oncology, Biology, Physics. 34, 2, s. 421-7 7 s.

Is there a radiobiologic basis for improving the treatment of advanced stage cervical cancer?

Lindegaard, J. C., Overgaard, J., Bentzen, S. M. & Pedersen, D., 1 jan. 1996, I : Journal of the National Cancer Institute Monographs. 21, s. 105-112 8 s.

Effect of radiation dose rate and Cyclophosphamide on late pulmonary toxicity after total body radiation in a mouse model

Safwat, A., Nielsen, O. S., El-Badawy, S. & Overgaard, J., jan. 1996, I : International Journal of Radiation Oncology, Biology, Physics. 34, 1, s. 85-91 7 s.

Modification of Hypoxia-Induced Radioresistance in Tumors by the Use of Oxygen and Sensitizers

Overgaard, J. & Horsman, M. R., jan. 1996, I : Seminars in Radiation Oncology. 6, 1, s. 10-21 12 s.

A comparison of the physiological effects of RSU1069 and RB6145 in the SCCVII murine tumour

Wood, P. J., Horsman, M. R., Khalil, A. A., Steinberg, F., Streffer, C., Overgaard, J., Stratford, I. J. & Adams, G. E., 1996, I : Acta Oncologica. 35, 8, s. 989-94 6 s.

Cancer registration in the Arctic--a useful research tool

Storm, H. H. & Overgaard, J., 1996, I : Acta Oncologica. 35, 5, s. 521-522 2 s.

The in vivo interaction between flavone acetic acid and hyperthermia

Horsman, M. R., Sampson, L. E., Chaplin, D. J. & Overgaard, J., 1996, I : International Journal of Hyperthermia. 12, 6, s. 779-89 11 s.

Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumours

Horsman, M. R., Nordsmark, M., Høyer, M. & Overgaard, J., dec. 1995, I : B J C. 72, 6, s. 1474-1478 5 s.

Selective assessment of in vitro radiosensitivity of tumour cells and fibroblasts from biopsies using immunohistochemical identification of colonies in the soft agar clonogenic assay

Stausbøl-Grøn, B., Nielsen, O. S., Bentzen, S. M. & Overgaard, J., nov. 1995, I : Radiotherapy & Oncology. 37, 2, s. 87-99 13 s.

Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now!

Bentzen, S. M., Vaeth, M., Pedersen, D. E. & Overgaard, J., 30 jul. 1995, I : International Journal of Radiation Oncology, Biology, Physics. 32, 5, s. 1531-1534 4 s.

Late renal damage after total body irradiation and bone marrow transplantation in a mouse model: effect of radiation fractionation

Safwat, A. A., Nielsen, O. S., el-Badawy, S. & Overgaard, J., jun. 1995, I : European Journal of Cancer. 31A, 6, s. 987-992 6 s.

Late renal damage after total body radiation and bone marrow transplantation in a mouse model: Effect of radiation fractionation

Safwat, A., Nielsen, O. S., El-Badawy, S. & Overgaard, J., jun. 1995, I : European Journal of Cancer. 31A, 6, s. 987-992 6 s.

About tolerance and quality. An important notice to all radiation oncologists

Overgaard, J. & Bartelink, H., apr. 1995, I : Radiotherapy & Oncology. 35, 1, s. 1-3 3 s.

Quality assurance in radiotherapy. European Society for Therapeutic Radiology and Oncology Advisory Report to the Commission of the European Union for the 'Europe Against Cancer Programme'

Thwaites, D., Scalliet, P., Leer, J. W. & Overgaard, J., apr. 1995, I : Radiotherapy & Oncology. 35, 1, s. 61-73 13 s.

Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology

Overgaard, J., Gonzalez Gonzalez, D., Hulshof, M. C., Arcangeli, G., Dahl, O., Mella, O. & Bentzen, S. M., 4 mar. 1995, I : Lancet. 345, 8949, s. 540-3 4 s.

Renal damage after total body irradiation in a mouse model for bone marrow transplantation: Effect of radiation dose rate

Safwat, A., Nielsen, O. S., El-Bakky, H. A. & Overgaard, J., mar. 1995, I : Radiotherapy & Oncology. 34, 3, s. 203-209 7 s.

Relationship between tumour oxygenation, bioenergetic status and radiobiological hypoxia in an experimental model

Nordsmark, M., Grau, C., Horsman, M. R., Jörgensen, H. S. & Overgaard, J., 1 jan. 1995, I : Acta Oncologica. 34, 3, s. 329-34 6 s.

Reoxygenation in a C3H mouse mammary carcinoma. The importance of chronic rather than acute hypoxia

Horsman, M. R., Grau, C. & Overgaard, J., 1 jan. 1995, I : Acta Oncologica. 34, 3, s. 325-8 4 s.

A century with hyperthermic oncology in Scandinavia

Dahl, O. & Overgaard, J., 1995, I : Acta oncologica (Stockholm, Sweden). 34, 8, s. 1075-83 9 s.

Effects of step-down and step-up heating on the development of thermotolerance in a C3H mammary carcinoma in vivo

Lindegaard, J. C., Nielsen, O. S. & Overgaard, J., 1995, I : International Journal of Hyperthermia. 11, 2, s. 231-9 9 s.

Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone

Pedersen, D., Søgaard, H., Overgaard, J. & Bentzen, S. M., 1995, I : Acta Oncologica. 34, 6, s. 787-95 9 s.

The ability of nicotinamide to inhibit the growth of a C3H mouse mammary carcinoma

Horsman, M. R., Khalil, A. A., Chaplin, D. J. & Overgaard, J., 1995, I : Acta Oncologica. 34, 3, s. 443-6 4 s.

The effect of castration on tumor growth rate and cell kinetics in hormone sensitive and hormone insensitive rat prostatic adenocarcinomas

Salling, L. N., Høyer, M. & Overgaard, J., 1995, I : Scandinavian Journal of Urology and Nephrology. Supplement. 172, s. 73-79 7 s.

The importance of determining necrotic fraction when studying the effect of tumour volume on tissue oxygenation

Khalil, A. A., Horsman, M. R. & Overgaard, J., 1995, I : Acta Oncologica. 34, 3, s. 297-300 4 s.

The in vivo interaction between vincristine and radiation in a C3H mammary carcinoma and the feet of CDF1 mice

Grau, C., Høyer, M. & Overgaard, J., 1 dec. 1994, I : International Journal of Radiation Oncology, Biology, Physics. 30, 5, s. 1141-1146 6 s.

Quantitative magnetic resonance for assessment of radiation fibrosis after post-mastectomy radiotherapy

Johansen, J., Taagehøj, F., Christensen, T., Overgaard, J. & Overgaard, M., dec. 1994, I : British Journal of Radiology. 67, 804, s. 1238-1242 5 s.

Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy

Johansen, J., Bentzen, S. M., Overgaard, J. & Overgaard, M., okt. 1994, I : International Journal of Radiation Biology. 66, 4, s. 407-12 6 s.

Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix

Pedersen, D., Bentzen, S. M. & Overgaard, J., 30 jul. 1994, I : International Journal of Radiation Oncology, Biology, Physics. 29, 5, s. 941-52 12 s.

Effect of carbon monoxide breathing on hypoxia and radiation response in the SCCVII tumor in vivo

Grau, C., Nordsmark, M., Khalil, A. A., Horsman, M. R. & Overgaard, J., 15 jun. 1994, I : International Journal of Radiation Oncology, Biology, Physics. 29, 3, s. 449-54 6 s.

Importance of nicotinamide dose on blood pressure changes in mice and humans

Horsman, M. R., Christensen, K. L. & Overgaard, J., 15 jun. 1994, I : International Journal of Radiation Oncology, Biology, Physics. 29, 3, s. 455-8 4 s.

Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation

Horsman, M. R., Khalil, A. A., Siemann, D. W., Grau, C., Hill, S. A., Lynch, E. M., Chaplin, D. J. & Overgaard, J., 15 jun. 1994, I : International Journal of Radiation Oncology, Biology, Physics. 29, 3, s. 439-42 4 s.

Influence of sampling time on assessment of potential doubling time

Høyer, M., Bentzen, S. M., Salling, L. N. & Overgaard, J., 1 jun. 1994, I : Cytometry. 16, 2, s. 144-151 8 s.

Patient-to-Patient Variability in the Expression of Radiation-Induced Normal Tissue Injury

Bentzen, S. M. & Overgaard, J., apr. 1994, I : Seminars in Radiation Oncology. 4, 2, s. 68-80 13 s.

Deep heating using a movable applicator phased array hyperthermia system. A preclinical feasibility study

Raskmark, P., Hornsleth, S. N., Salling, M. H. N., Lindegaard, J. C. & Overgaard, J., 1 jan. 1994, I : Acta Oncologica. 33, 4, s. 451-5 5 s.

The relationship between carbon monoxide breathing, tumour oxygenation and local tumour control in the C3H mammary carcinoma in vivo

Grau, C., Khalil, A. A., Nordsmark, M., Horsman, M. R. & Overgaard, J., 1 jan. 1994, I : British Journal of Cancer. 69, 1, s. 50-7 8 s.

Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors

Overgaard, J., 1994, I : Oncology Research. 6, 10-11, s. 509-18 10 s.

Continuous or split-course combined external and intracavitary radiotherapy of locally advanced carcinoma of the uterine cervix

Pedersen, D., Bentzen, S. M. & Overgaard, J., 1994, I : Acta Oncologica. 33, 5, s. 547-55 9 s.

European School of Oncology Advisory Report to the Commission of the European Communities for the "Europe Against Cancer Programme." Continuing Medical Education in Oncology within the European Union

Armand, J. P., Alberto, P., Costa, A., Estape, J., Jones, R., Overgaard, J. & Sherman, C. D., 1994, I : European Journal of Cancer. 30A, 8, s. 1145-1148 4 s.

Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity

Nordsmark, M., Bentzen, S. M. & Overgaard, J., 1994, I : Acta Oncologica. 33, 4, s. 383-9 7 s.

Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing

Horsman, M. R., Nordsmark, M., Khalil, A. A., Hill, S. A., Chaplin, D. J., Siemann, D. W. & Overgaard, J., 1994, I : Acta Oncologica. 33, 4, s. 371-6 6 s.

The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment

Horsman, M. R., Siemann, D. W., Nordsmark, M., Khalil, A. A., Overgaard, J. & Chaplin, D. J., 1994, I : Advances in Experimental Medicine and Biology. 361, s. 635-642 8 s.

Use of tetrahydraindazolone dicarboxylic acid (HIDA) to improve the therapeutic effect in vivo of combined cisplatin, heat and radiation treatment

Overgaard, J., Radacic, M., Skaric, D., Skaric, V., Horsman, M. R., Lindegaard, J. C., Jercic, J. & Lindegaard, J. C., dec. 1993, I : International Journal of Hyperthermia. 9, 6, s. 821-30 10 s.

The effect of sequence and time interval between cyclophosphamide and total body irradiation on lung and bone marrow damage following bone marrow transplantation in mice

Nielsen, O. S., Safwat, A. & Overgaard, J., okt. 1993, I : Radiotherapy & Oncology. 29, 1, s. 51-59 9 s.

Histological grade, DNA ploidy and mean nuclear volume as prognostic factors in prostatic cancer

Nielsen, K., Overgaard, J., Bentzen, S. M. & Bruun, E., aug. 1993, I : A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica. 101, 8, s. 614-20 7 s.

Reporting radiotherapeutic complications in patients with uterine cervical cancer. The importance of latency and classification system

Pedersen, D., Bentzen, S. M. & Overgaard, J., aug. 1993, I : Radiotherapy & Oncology. 28, 2, s. 134-41 8 s.

Relationship between radiobiological hypoxia and direct estimates of tumour oxygenation in a mouse tumour model

Horsman, M. R., Khalil, A. A., Nordsmark, M., Grau, C. & Overgaard, J., 1 jul. 1993, I : Radiotherapy & Oncology. 28, 1, s. 69-71 3 s.

Nicotinamide pharmacokinetics in humans and mice: A comparative assessment and the implications for radiotherapy

Horsman, M. R., Høyer, M., Honess, D. J., Dennis, I. F. & Overgaard, J., maj 1993, I : Radiotherapy & Oncology. 27, 2, s. 131-139 9 s.

A randomized feasibility study evaluating the effect of radiotherapy alone or combined with 5-fluorouracil in the treatment of locally recurrent or inoperable colorectal carcinoma

Overgaard, M., Bertelsen, K., Dalmark, M., Gadeberg, C. C., Maase, H. V. D., Overgaard, J. & Sell, A., 1993, I : Acta Oncologica. 32, 5, s. 547-53 7 s.

Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity

Bentzen, S. M., Overgaard, M. & Overgaard, J., 1993, I : European journal of cancer (Oxford, England : 1990). 29A, 10, s. 1373-6 4 s.

Influence of time between total body irradiation and cyclophosphamide in bone marrow transplantation. A study on mice.

Nielsen, O. S., Safwat, A. & Overgaard, J., 1993, I : Radiology and Oncology. 29, s. 51-59

Is kidney the real dose limiting organ after total body irradiation and bone marrow transplatation?

Safwat, A., Nielsen, O. S. & Overgaard, J., 1993, I : European Journal of Cancer. 29A, 6, s. 921

Is kidney the real dose-limiting organ after total body irradiation and bone marrow transplantation?

Safwat, A. A., Nielsen, O. S. & Overgaard, J., 1993, I : European journal of cancer (Oxford, England : 1990). 29A, 6, s. 929 1 s.

Fractionation sensitivity and latency of late radiation injury to the mouse urinary bladder

Bentzen, S. M., Lundbeck, F., Christensen, L. L. & Overgaard, J., dec. 1992, I : Radiotherapy & Oncology. 25, 4, s. 301-7 7 s.

Auditory brain stem responses in patients after radiation therapy for nasopharyngeal carcinoma

Grau, C., Møller, K., Overgaard, M., Overgaard, J. & Elbrønd, O., 15 nov. 1992, I : Cancer. 70, 10, s. 2396-401 6 s.

BW12C-induced changes in haemoglobin-oxygen affinity in mice and its influence on the radiation response of a C3H mouse mammary carcinoma

Horsman, M. R. & Overgaard, J., sep. 1992, I : Radiotherapy & Oncology. 25, 1, s. 43-8 6 s.

Malignant parotid tumors in 110 consecutive patients: treatment results and prognosis

Pedersen, D., Overgaard, J., Søgaard, H., Elbrønd, O. & Overgaard, M., sep. 1992, I : Laryngoscope. 102, 9, s. 1064-9 6 s.

Stereologic, histopathologic, flow cytometric, and clinical parameters in the prognostic evaluation of 74 patients with intraoral squamous cell carcinomas

Bundgaard, T., Sørensen, F. B., Gaihede, M., Søgaard, H. & Overgaard, J., 1 jul. 1992, I : Cancer. 70, 1, s. 1-13 13 s.

Early and late changes in the normal mouse bladder reservoir function due to irradiation and cis-DDP

Lundbeck, F. & Overgaard, J., jul. 1992, I : B J C. 66, 1, s. 99-105 7 s.

Carcinoma of the nasopharynx: Analysis of treatment results in 167 consecutively admitted patients

Johansen, L. V., Mestre, M. & Overgaard, J., jun. 1992, I : Head & Neck (Print Edition). 14, 3, s. 200-207 8 s.

Cisplatin and hyperthermia treatment of a C3H mammary carcinoma in vivo. Importance of sequence, interval, drug dose, and temperature

Lindegaard, J. C., Radacic, M., Khalil, A. A., Horsman, M. R. & Overgaard, J., 1 jan. 1992, I : Acta Oncologica. 31, 3, s. 347-351 5 s.

Effect of carboxyhemoglobin on tumor oxygen unloading capacity in patients with squamous cell carcinoma of the head and neck

Overgaard, J., Nielsen, J. E. & Grau, C., 1 jan. 1992, I : International Journal of Radiation Oncology, Biology, Physics. 22, 3, s. 407-10 4 s.

Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ

Grau, C. & Overgaard, J., 1 jan. 1992, I : Cancer Chemotherapy and Pharmacology. 30, 4, s. 277-80 4 s.

Improving the radiation response in a C3H mouse mammary carcinoma by normobaric oxygen or carbogen breathing

Grau, C., Horsman, M. R. & Overgaard, J., 1 jan. 1992, I : International Journal of Radiation Oncology, Biology, Physics. 22, 3, s. 415-419 5 s.

Influence of carboxyhemoglobin level on tumor growth, blood flow, and radiation response in an experimental model

Grau, C., Horsman, M. R. & Overgaard, J., 1 jan. 1992, I : International Journal of Radiation Oncology, Biology, Physics. 22, 3, s. 421-424 4 s.

Interaction of misonidazole, hyperthermia, and irradiation in a C3H mammary carcinoma and its surrounding skin in vivo

Mao, H. S., Grau, C. & Overgaard, J., 1 jan. 1992, I : International Journal of Radiation Oncology, Biology, Physics. 22, 1, s. 115-122 8 s.

Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis

Bentzen, S. M., Balslev, I., Pedersen, M., Teglbjaerg, P. S., Hanberg-Sørensen, F., Bone, J., Jacobsen, N. O., Sell, A., Overgaard, J., Bertelsen, K., Hage, E., Fenger, C., Kronborg, O., Hansen, L., Høstrup, H. & Nørgaard-Pedersen, B., jan. 1992, I : B J C. 65, 1, s. 102-107 6 s.

Biochemical and physiological changes induced by nicotinamide in a C3H mouse mammary carcinoma and CDF1 mice

Horsman, M. R., Kristjansen, P. E. G., Mizuno, M., Christensen, K. L., Chaplin, D. J., Quistorff, B. & Overgaard, J., 1992, I : International Journal of Radiation Oncology, Biology, Physics. 22, 3, s. 451-454 4 s.

Education in radiation oncology in Europe

Leer, J. W., Davelaar, J., Overgaard, J. & Heeren, G., 1992, I : International Journal of Radiation Oncology, Biology, Physics. 24, 5, s. 819-23 5 s.

Overcoming tumour radiation resistance resulting from acute hypoxia

Horsman, M. R. & Overgaard, J., 1992, I : European journal of cancer (Oxford, England : 1990). 28A, 12, s. 2084-5 2 s.

Overcoming tumour radiation resistance resulting from acute hypoxia

Horsman, M. R. & Overgaard, J., 1992, I : European journal of cancer (Oxford, England : 1990). 28A, 4-5, s. 717-718 2 s.

Relationship between the hydralazine-induced changes in murine tumor blood supply and mouse blood pressure

Horsman, M. R., Christensen, K. L. & Overgaard, J., 1992, I : International Journal of Radiation Oncology, Biology, Physics. 22, 3, s. 455-8 4 s.

The European core curriculum on radiotherapy

Leer, J. W. H., Overgaard, J. & Heeren, G., 1992, I : International Journal of Radiation Oncology, Biology, Physics. 24, 5, s. 813-814 2 s.

The European core curriculum on radiotherapy

Leer, J. W. H., Overgaard, J. & Heeren, G., nov. 1991, I : Radiotherapy & Oncology. 22, 3, s. 153-155 3 s.

Effect of step-down heating on the interaction between heat and radiation in a C3H mammary carcinoma in vivo

Lindegaard, J. C., Grau, C. & Overgaard, J., 1 okt. 1991, I : International Journal of Radiation Biology. 60, 4, s. 707-721 15 s.

Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinoma

Grau, C., Møller, K., Overgaard, M., Overgaard, J. & Elbrønd, O., 1 aug. 1991, I : International Journal of Radiation Oncology, Biology, Physics. 21, 3, s. 723-728 6 s.

Clinical radiobiology of squamous cell carcinoma of the oropharynx

Bentzen, S. M., Johansen, L. V., Overgaard, J. & Thames, H. D., jun. 1991, I : International Journal of Radiation Oncology, Biology, Physics. 20, 6, s. 1197-206 10 s.

Radiosensitizing and cytotoxic properties of mitomycin C in a C3H mouse mammary carcinoma in vivo

Grau, C. & Overgaard, J., 1 feb. 1991, I : International Journal of Radiation Oncology, Biology, Physics. 20, 2, s. 265-269 5 s.

Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo

Overgaard, J., Radacic, M. M. & Grau, C., 15 jan. 1991, I : Cancer Research. 51, 2, s. 707-711 5 s.

The potential of using hyperthermia to eliminate radioresistant hypoxic cells

Overgaard, J., Grau, C., Lindegaard, J. C. & Horsman, M. R., 1 jan. 1991, I : Radiotherapy & Oncology. 20 , Suppl 1, s. 113-116 4 s.

A comparison between the effect of step-down heating in a tumour and a normal tissue in vivo

Lindegaard, J. C., Nielsen, O. S. & Overgaard, J., 1991, I : International Journal of Hyperthermia. 7, 3, s. 519-26 8 s.

Hydralazine-induced changes in tissue perfusion and radiation response in a C3H mammary carcinoma and mouse normal tissues

Fisker, R. V., Horsman, M. R. & Overgaard, J., 1991, I : Acta Oncologica. 30, 5, s. 641-647 7 s.

Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85

Overgaard, J., Sand Hansen, H., Lindeløv, B., Overgaard, M., Jørgensen, K., Rasmusson, B. & Berthelsen, A., 1991, I : Radiotherapy & Oncology. 20 , Suppl 1, s. 143-9 7 s.

Resources and productivity in radiation oncology in Denmark, Finland, Iceland, Norway and Sweden during 1987

Lote, K., Möller, T., Nordman, E., Overgaard, J. & Sveinsson, T., 1991, I : Acta Oncologica. 30, 5, s. 555-561 7 s.

The effect of combining flavone acetic acid and hyperthermia on the growth of a C3H mammary carcinoma in vivo

Horsman, M. R., Chaplin, D. J. & Overgaard, J., 1991, I : International Journal of Radiation Biology. 60, 1-2, s. 385-388 4 s.

The use of blood flow modifiers to improve the treatment response of solid tumors

Horsman, M. R., Chaplin, D. J. & Overgaard, J., 1991, I : Radiotherapy & Oncology. 20, Suppl 1, s. 47-52 6 s.

Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells

Horsman, M. R., Chaplin, D. J. & Overgaard, J., 1 dec. 1990, I : Cancer Research. 50, 23, s. 7430-7436 7 s.

Evaluation of radiotherapy in high-risk breast cancer patients: report from the Danish Breast Cancer Cooperative Group (DBCG 82) Trial

Overgaard, M., Christensen, J. J., Johansen, H., Nybo-Rasmussen, A., Rose, C., van der Kooy, P., Panduro, J., Laursen, F., Kjær, M., Sørensen, N. E., Gadeberg, C. C., Hjelm-Hansen, M., Overgaard, J., Andersen, K. W. & Zedeler, K., nov. 1990, I : International Journal of Radiation Oncology, Biology, Physics. 19, 5, s. 1121-1124 4 s.

Radiation enteritis: mucosal regeneration and stromal reaction of the small intestine after irradiation

Matsui, M., Jingu, K., Masuda, K., Kamura, T., Tsukamoto, N., Matsuyama, T. & Overgaard, J., okt. 1990, I : Gan No Rinsho. 36, 13, s. 2305-2312 8 s.

The influence of radiation dose on the magnitude and kinetics of reoxygenation in a C3H mammary carcinoma

Grau, C. & Overgaard, J., 1 jun. 1990, I : Radiation Research. 122, 3, s. 309-15 7 s.

Primary radiotherapy of T1 squamous cell carcinoma of the larynx: Analysis of 478 patients treated from 1963 to 1985

Johansen, L. V., Overgaard, J., Hjelm-Hansen, M. & Gadeberg, C., jun. 1990, I : International Journal of Radiation Oncology, Biology, Physics. 18, 6, s. 1307-1313 7 s.

Effect of radiation on glucose absorption in the mouse jejunum in vivo

Overgaard, J. & Matsui, M., maj 1990, I : Radiotherapy & Oncology. 18, 1, s. 71-7 7 s.

The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivo

Horsman, M. R., Wood, P. J., Chaplin, D. J., Brown, J. & Overgaard, J., maj 1990, I : Radiotherapy & Oncology. 18, 1, s. 49-57 9 s.

Blood transfusion and prognosis in Dukes' B and C colorectal cancer

Bentzen, S. M., Balslev, I., Pedersen, M., Teglbjærg, P. S., Hanberg-Sørensen, F., Bone, J., Jacobsen, N. O., Sell, A., Overgaard, J., Bertelsen, K., Hage, E., Fenger, C., Kronborg, O., Hansen, L., Høstrup, H. & Nørgaard-Pedersen, B., apr. 1990, I : European journal of cancer (Oxford, England : 1990). 26, 4, s. 457-63 7 s.

Invasive blood pressure measurements in restrained but non-anaesthetized mice

Christensen, K. L., Horsman, M. R. & Overgaard, J., feb. 1990, I : In Vivo. 4, 1, s. 13-16 4 s.

Cytotoxic effect of misonidazole and cyclophosphamide on aerobic and hypoxic cells in a C3H mammary carcinoma in vivo

Grau, C., Bentzen, S. M. & Overgaard, J., 1 jan. 1990, I : British Journal of Cancer. 61, 1, s. 61-4 4 s.

The in vivo response of a C3H mammary carcinoma to treatment with misonidazole, cyclophosphamide and radiation

Grau, C., Zachariae, C., Mao, H. S. & Overgaard, J., 1 jan. 1990, I : Acta Oncologica. 29, 6, s. 769-74 6 s.

Does variation in the in vitro cellular radiosensitivity explain the shallow clinical dose-control curve for malignant melanoma?

Bentzen, S. M., Thames, H. D. & Overgaard, J., jan. 1990, I : International Journal of Radiation Biology. 57, 1, s. 117-126 10 s.

Hyperthermia in clinical oncology

Reinhold, H. S. & Overgaard, J., 1990, I : European Journal of Cancer. 26, 8, s. 915-6 2 s.

Step-down heating in a C3H mammary carcinoma in vivo: effects of varying the time and temperature of the sensitizing treatment

Lindegaard, J. C. & Overgaard, J., 1990, I : International Journal of Hyperthermia. 6, 3, s. 607-617 11 s.

Clinical radiobiology of malignant melanoma

Bentzen, S. M., Overgaard, J., Thames, H. D., Overgaard, M., Vejby Hansen, P., von der Maase, H. & Meder, J., nov. 1989, I : Radiotherapy & Oncology. 16, 3, s. 169-82 14 s.

Early and late normal-tissue injury after postmastectomy radiotherapy alone or combined with chemotherapy

Bentzen, S. M., Overgaard, M., Thames, H. D., Christensen, J. J. & Overgaard, J., nov. 1989, I : International Journal of Radiation Biology. 56, 5, s. 711-715 5 s.

Sensitization of hypoxic tumour cells--clinical experience

Overgaard, J., nov. 1989, I : International Journal of Radiation Biology. 56, 5, s. 801-11 11 s.

Cystometric evaluation of early and late irradiation damage to the mouse urinary bladder

Lundbeck, F., Ulsø, N. & Overgaard, J., aug. 1989, I : Radiotherapy & Oncology. 15, 4, s. 383-392 10 s.

Radiosensitization by nicotinamide in tumors and normal tissues: the importance of tissue oxygenation status

Horsman, M. R., Hansen, P. V. & Overgaard, J., maj 1989, I : International Journal of Radiation Oncology, Biology, Physics. 16, 5, s. 1273-1276 4 s.

Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix

Overgaard, J., Bentzen, S. M., Kolstad, P., Kjørstad, K., Davy, M., Bertelsen, K., Mäntyla, M., Frankendal, B., Skryten, A., Löftquist, I., Pedersen, M., Sell, A. & Hammer, R., apr. 1989, I : International Journal of Radiation Oncology, Biology, Physics. 16, 4, s. 1069-1072 4 s.

Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx. Report from the DAHANCA 2 study

Overgaard, J., Hansen, H. S., Andersen, A. P., Hjelm-Hansen, M., Jørgensen, K., Sandberg, E., Berthelsen, A., Hammer, R. & Pedersen, M., apr. 1989, I : International Journal of Radiation Oncology, Biology, Physics. 16, 4, s. 1065-1068 4 s.

The current and potential role of hyperthermia in radiotherapy

Overgaard, J., mar. 1989, I : International Journal of Radiation Oncology, Biology, Physics. 16, 3, s. 535-49 15 s.

Photodynamic therapy of experimental intraocular retinoblastomas--dose-response relationships to light energy and photofrin II

Winther, J. & Overgaard, J., feb. 1989, I : Acta Ophthalmologica. 67, 1, s. 44-50 7 s.

Mechanism for the reduction of tumour hypoxia by nicotinamide and the clinical relevance for radiotherapy

Horsman, M. R., Overgaard, J., Christensen, K. L., Trotter, M. J. & Chaplin, D. J., 1989, I : Biomedica Biochimica Acta. 48, 2-3, s. S251-4

Effect of cancer chemotherapy on the hypoxic fraction of a solid tumor measured using a local tumor control assay

Grau, C. & Overgaard, J., 1 dec. 1988, I : Radiotherapy & Oncology. 13, 4, s. 301-9 9 s.

Misonidazole neuropathy. A prospective study

Melgaard, B., Køhler, O., Sand Hansen, H., Overgaard, J., Munck-Hansen, J. & Paulson, O. B., nov. 1988, I : Journal of Neurooncology. 6, 3, s. 227-230 4 s.

Effect of combined 5-fluorouracil and radiation on murine hematopoietic tissue

Nielsen, O. S., von der Maase, H. & Overgaard, J., okt. 1988, I : Radiotherapy & Oncology. 13, 2, s. 145-152 8 s.

Mechanism of action of the selective tumor radiosensitizer nicotinamide

Horsman, M. R., Brown, J. M., Hirst, V. K., Lemmon, M. J., Wood, P. J., Dunphy, E. P. & Overgaard, J., sep. 1988, I : International Journal of Radiation Oncology, Biology, Physics. 15, 3, s. 685-690 6 s.

A regression analysis of prognostic factors after resection of Dukes' B and C carcinoma of the rectum and rectosigmoid. Does post-operative radiotherapy change the prognosis?

Bentzen, S. M., Balslev, I., Pedersen, M., Teglbjærg, P. S., Hanberg-Sørensen, F., Bone, J., Jacobsen, N. O., Overgaard, J., Sell, A. & Bertelsen, K., aug. 1988, I : B J C. 58, 2, s. 195-201 7 s.

Predictive value of flow cytometric DNA-analysis on fresh retinoblastoma tissue

Winther, J., Ehlers, N., Jensen, O. A., Overgaard, J. & Prause, J. U., apr. 1988, I : Acta Ophthalmologica (Online). 66, 2, s. 217-9 3 s.

Effect of step-down heating on hyperthermic radiosensitization in an experimental tumor and a normal tissue in vivo

Lindegaard, J. C. & Overgaard, J., 1 feb. 1988, I : Radiotherapy & Oncology. 11, 2, s. 143-51 9 s.

Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx

Overgaard, J., Hjelm-Hansen, M., Johansen, L. V. & Andersen, A. P., 1988, I : Acta Oncologica. 27, 2, s. 147-152 6 s.

International Clinical Trials in Radiation Oncology. Hyperthermia trials

Arcangeli, G., Overgaard, J., Gonzalez Gonzalez, D. & Shrivastava, P. N., 1988, I : International Journal of Radiation Oncology, Biology, Physics. 14, Suppl 1, s. S93-109 17 s.

Is there a role for hyperthermia in gastrointestinal tract cancer

Overgaard, J. & Overgaard, M., 1988, I : Recent Results in Cancer Research. 110, s. 244-253 9 s.

Postmastectomy irradiation in high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group trials

Overgaard, M., Christensen, J. J., Johansen, H., Nybo-Rasmussen, A., Brincker, H., van der Kooy, P., Frederiksen, P. L., Laursen, F., Panduro, J., Sørensen, N. E., Gadeberg, C. C., Hjelm-Hansen, M., Overgaard, J., West, K. & Zedeler, K., 1988, I : Acta Oncologica. 27, 6A, s. 707-14 8 s.

Some methodological problems in estimating radiobiological parameters from clinical data. Alpha/beta ratios and electron RBE for cutaneous reactions in patients treated with postmastectomy radiotherapy

Bentzen, S. M., Christensen, J. J., Overgaard, J. & Overgaard, M., 1988, I : Acta Oncologica. 27, 2, s. 105-116 12 s.

The interaction between RSU-1069, hydralazine and hyperthermia in a C3H mammary carcinoma as assessed by tumour growth delay

Horsman, M. R., Overgaard, J. & Chaplin, D. J., 1988, I : Acta oncologica (Stockholm, Sweden). 27, 6b, s. 861-2 2 s.

Hyperthermia as an adjuvant to radiotherapy. Review of the randomized multicenter studies of the European Society for Hyperthermic Oncology

Overgaard, J., jul. 1987, I : Strahlentherapie und Onkologie. 163, 7, s. 453-457 5 s.

Experimental studies of photodynamic therapy in a retinoblastoma-like tumour

Winther, J. & Overgaard, J., 1987, I : Acta Ophthalmologica. 182, s. 140-143 4 s.

Hyperthermia as an adjuvant to radiotherapy in the treatment of malignant melanoma

Overgaard, J. & Overgaard, M., 1987, I : International Journal of Hyperthermia. 3, 6, s. 483-501 19 s.

Orgotein in radiation treatment of bladder cancer - A report on allergic reactions and lack of radioprotective effect

Nielsen, O. S., Overgaard, J., Overgaard, M., Steenholdt, S., Jakobsen, A. & Sell, A., 1987, I : Acta Oncologica. 26, 2, s. 101-104 4 s.

Regeneration of murine hematopoietic stem cells after 5-fluorouracil and irradiation.

Nielsen, O. S., Maase, H. V. D. & Overgaard, J., 1987, Radiation Research.. Fielden, E. M., Fowler, J. F., Hendry, J. H. & Scott, D. (red.). London and Philadelphia: Taylor & Francis, Bind 1. s. 303

Some problems related to the clinical use of thermal isoeffect doses

Overgaard, J., 1987, I : International Journal of Hyperthermia. 3, 4, s. 329-36 8 s.

Major or local surgery for cure in early rectal and sigmoid carcinoma--a prospective evaluation

Balslev, I., Pedersen, M., Teglbjærg, P. S., Hanberg-Sørensen, F., Bone, J., Jacobsen, N. O., Overgaard, J., Sell, A., Bertelsen, K., Hage, E., Hansen, L., Kronborg, O., Høstrup, H. & Nørgaard-Pedersen, B., dec. 1986, I : European Journal of Surgical Oncology. 12, 4, s. 373-377 5 s.

Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study

Balslev, I., Pedersen, M., Teglbjærg, P. S., Hanberg-Soerensen, F., Bone, J., Jacobsen, N. O., Overgaard, J., Sell, A., Bertelsen, K., Hage, E., Hansen, L., Kronborg, O., Høstrup, H. & Nørgaard-Pedersen, B., 1 jul. 1986, I : Cancer. 58, 1, s. 22-28 7 s.

The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study

Overgaard, J., jun. 1986, I : International Journal of Radiation Oncology, Biology, Physics. 12, 6, s. 867-872 6 s.

Identification of thermal model for human tissue

Knudsen, M. & Overgaard, J., maj 1986, I : IEEE transactions on bio-medical engineering. 33, 5, s. 477-485 9 s.

Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival

Overgaard, J., Hansen, H. S., Jørgensen, K. & Hjelm Hansen, M., apr. 1986, I : International Journal of Radiation Oncology, Biology, Physics. 12, 4, s. 515-521 7 s.

Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice

von der Maase, H. V. D., Overgaard, J. & Væth, M., mar. 1986, I : Radiotherapy & Oncology. 5, 3, s. 245-57 13 s.

Some factors of importance in the radiation treatment of malignant melanoma

Overgaard, J., Overgaard, M., Hansen, P. V. & von der Maase, H., mar. 1986, I : Radiotherapy & Oncology. 5, 3, s. 183-192 10 s.

A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma

Overgaard, J., Maase, H. V. D. & Overgaard, M., okt. 1985, I : International Journal of Radiation Oncology, Biology, Physics. 11, 10, s. 1837-9 3 s.

Interactions of radiation and cancer chemotherapeutic drugs in a C3H mouse mammary carcinoma

von der Maase, H. & Overgaard, J., apr. 1985, I : Acta radiologica. Oncology. 24, 2, s. 181-7 7 s.

Studies on fractionated hyperthermia in L1A2 tumour cells in vitro. Response to multiple equal heat fractions

Nielsen, O. S. & Overgaard, J., apr. 1985, I : International Journal of Hyperthermia. 1, 2, s. 193-203 11 s.

Isotherm mapping in hyperthermia using subtraction X-ray computed tomography

Bentzen, S. M., Overgaard, J. & Jørgensen, J., okt. 1984, I : Radiotherapy & Oncology. 2, 3, s. 255-60 6 s.

A phase I clinical study of Nimorazole as a hypoxic radiosensitizer

Timothy, A. R., Overgaard, J. & Overgaard, M., sep. 1984, I : International Journal of Radiation Oncology, Biology, Physics. 10, 9, s. 1765-8 4 s.

A hyperthermia system using a new type of inductive applicator

Andersen, J. B., Baun, A. H., Harmark, K., Heinzl, L., Raskmark, P. & Overgaard, J., jan. 1984, I : IEEE transactions on bio-medical engineering. 31, 1, s. 21-7 7 s.

Dose-response relationship for radiation therapy of recurrent, residual, and primarily inoperable colorectal cancer

Overgaard, M., Overgaard, J. & Sell, A., jan. 1984, I : Radiotherapy & Oncology. 1, 3, s. 217-25 9 s.

Formula to estimate the thermal enhancement ratio of a single simultaneous hyperthermia and radiation treatment

Overgaard, J., 1984, I : Acta radiologica. Oncology. 23, 2-3, s. 135-9 5 s.

Histology as a method of detecting biological heat damage in tumours

Overgaard, J., nov. 1983, I : British Journal of Radiology. 56, 671, s. 894-5 2 s.

The importance of thermotolerance for the clinical treatment with hyperthermia

Overgaard, J. & Nielsen, O. S., nov. 1983, I : Radiotherapy & Oncology. 1, 2, s. 167-178 12 s.

Studies of the pharmacokinetic properties of nimorazole

Overgaard, J., Overgaard, M. & Timothy, A. R., jul. 1983, I : B J C. 48, 1, s. 27-34 8 s.

Influence of thermotolerance on the interaction between hyperthermia and radiation in a solid tumour in vivo

Nielsen, O. S., Overgaard, J. & Kamura, T., apr. 1983, I : British Journal of Radiology. 56, 664, s. 267-273 7 s.

Microcolony survival assay for jejunal crypt cells exposed to radiation alone and combined with cancer chemotherapeutic agents--methodological problems

von der Maase, H. & Overgaard, J., jan. 1983, I : International journal of radiation biology and related studies in physics, chemistry, and medicine. 43, 1, s. 45-56 12 s.

A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo

Overgaard, J., Overgaard, M., Nielsen, O. S., Kirstein Pedersen, A. & Timothy, A. R., dec. 1982, I : British Journal of Cancer. 46, 6, s. 904-911 8 s.

Importance of preheating temperature and time for the induction of thermotolerance in a solid tumour in vivo

Nielsen, O. S. & Overgaard, J., dec. 1982, I : British Journal of Cancer. 46, 6, s. 894-903

Influence of time and temperature on the kinetics of thermotolerance in L1A2 cells in vitro

Nielsen, O. S. & Overgaard, J., okt. 1982, I : Cancer Research. 42, 10, s. 4190-4196 7 s.

Postoperative radiotherapy in rectosigmoid cancer Dukes' B and C: interim report from a randomized multicentre study

Balslev, I., Pedersen, M., Teglbjærg, P. S., Hanberg-Sørensen, F., Bone, J., Jacobsen, N. O., Overgaard, J., Sell, A., Bertelsen, K., Hage, E., Hansen, L., Kronborg, O., Høstrup, H. & Nørgaard-Pedersen, B., okt. 1982, I : B J C. 46, 4, s. 551-6 6 s.

Arrhenius analysis of survival curves from thermotolerant and step-down heated L1A2 cells in vitro

Nielsen, O. S., Henle, K. J. & Overgaard, J., sep. 1982, I : Radiation Research. 91, 3, s. 468-482 5 s.

Influence of sequence and interval on the biological response to combined hyperthermia and radiation

Overgaard, J., jun. 1982, I : Journal of the National Cancer Institute Monographs. 61, s. 325-332 8 s.

Development of thermotolerance during fractionated hyperthermia in a solid tumor in vivo

Kamura, T., Nielsen, O. S., Overgaard, J. & Andersen, A. H., maj 1982, I : Cancer Research. 42, 5, s. 1744-1748 5 s.

Fractionated hyperthermia and development of thermotolerance. Effect of environmental factors.

Nielsen, O. S. & Overgaard, J., 1982, I : National Cancer Institute Monograph. 61, s. 133-135

Fractionated radiation and hyperthermia Experimental and clinical studies

Overgaard, J., 1 sep. 1981, I : Cancer. 48, 5, s. 1116-1123 8 s.

Experimental studies on the radiation-modifying effect of bleomycin in malignant and normal mouse tissue in vivo

Molin, J., Søgaard, P. E. & Overgaard, J., aug. 1981, I : Cancer Treatment Reports. 65, 7-8, s. 583-589 7 s.

Effect of hyperthermia on the hypoxic fraction in an experimental mammary carcinoma in vivo

Overgaard, J., mar. 1981, I : British Journal of Radiology. 639, s. 245-249 5 s.

Selective enhancement of radiation response in a C3H mammary carcinoma by cisplatin

Overgaard, J. & Khan, A. R., 1981, I : Cancer Treatment Reports. 65, 5-6, s. 501-503 3 s.

Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo

Overgaard, J., nov. 1980, I : International Journal of Radiation Oncology, Biology, Physics. 6, 11, s. 1507-1517 11 s.

Multifractionated hyperthermia treatment of malignant and normal tissue in vivo

Overgaard, J., Suit, H. D. & Walker, A. M., jun. 1980, I : Cancer Research. 40, 6, s. 2045-50 6 s.

Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue

Overgaard, J., jan. 1980, I : B J C. 41, 1, s. 10-21 12 s.

The role of tissue environmental factors on the kinetics and morphology of tumor cells exposed to hyperthermia

Overgaard, J. & Nielsen, O. S., 1980, I : New York Academy of Sciences. Annals. 335, s. 254-280 27 s.

Synergistic cell cycle kinetic effect of low doses of hyperthermia and radiation on tumour cells.

Bichel, P., Overgaard, J. & Nielsen, O. S., okt. 1979, I : European Journal of Cancer. 15, 10, s. 1191-1196

Time-temperature relationship th hyperthermic treatment of malignant and normal tissue in vivo

Overgaard, J. & Suit, H. D., aug. 1979, I : Cancer Research. 39, 8, s. 3248-3253 6 s.

Treatment of early carcinoma of the breast

Timothy, A. R., Overgaard, J., Overgaard, M. & Wang, C. C., 7 jul. 1979, I : Lancet. 2, 8132, s. 25-6 2 s.

Effect of extracellular Ph on thermotolerance and recovery of hyperthermic damage in vitro.

Nielsen, O. S. & Overgaard, J., jul. 1979, I : Cancer Research. 39, 7 Pt. 1, s. 2772-2778 7 s.

Hyperthermic radiosensitization of thermotolerant tumour cells in vitro

Nielsen, O. S. & Overgaard, J., feb. 1979, I : International Journal of Radiation Biology. 35, 2, s. 171-176 6 s.

Effect of local hyperthermia on the acute toxicity of misonidazole in mice

Overgaard, J., jan. 1979, I : B J C. 39, 1, s. 96-98 3 s.

Lack of radiation protective effect of orgotein in normal and malignant mammalian cells.

Overgaard, J., Nielsen, O. S., Overgaard, M., Steenholdt, S., Jakobsen, A. & Sell, A., 1979, I : Acta Radiologica. 18, s. 305-312

Effect of hyperthermia on malignant cells in vivo. A review and a hypothesis

Overgaard, J., jun. 1977, I : Cancer. 39, 6, s. 2637-2746 10 s.

Hyperthermic effect on exponential and plateau ascites tumor cells in vitro dependent on environmental pH1

Bichel, P. & Overgaard, J., maj 1977, I : Radiation Research. 70, 2, s. 449-454 6 s.

Hyperthermic tumour-cell devitalization in vivo

Overgaard, K. & Overgaard, J., maj 1977, I : Acta radiologica: therapy, physics, biology. 16, 1, s. 1-16 16 s.

The influence of hypoxia and acidity on the hyperthermic response of malignant cells in vitro

Overgaard, J. & Bichel, P., maj 1977, I : Radiology. 123, 2, s. 511-514 4 s.

Effect of hyperthermia and environmental acidity on the proteolytic activity in murine ascites tumor cells

Overgaard, J. & Poulsen, H. S., apr. 1977, I : National Cancer Institute. Journal (Print). 58, 4, s. 1159-1161 3 s.

Primary leiomyosarcoma of bone

Overgaard, J., Frederiksen, P., Helmig, O. & Jensen, O. M., apr. 1977, I : Cancer. 39, 4, s. 1664-1671 8 s.

Combined adriamycin and hyperthermia treatment of a murine mammary carcinoma in vivo

Overgaard, J., sep. 1976, I : Cancer Research. 36, 9 pt.1, s. 3077-3081 5 s.

Influence of extracellular pH on the viability and morphology of tumor cells exposed to hyperthermia

Overgaard, J., jun. 1976, I : National Cancer Institute. Journal (Print). 56, 6, s. 1243-1250 8 s.

Ultrastructure of a murine mammary carcinoma exposed to hyperthermia in vivo

Overgaard, J., mar. 1976, I : Cancer Research. 36, 3, s. 983-995 13 s.

Histologic and histochemical reactions in a mouse mammary carcinoma following exposure to combined heat-roentgen irradiation

Overgaard, K. & Overgaard, J., apr. 1975, I : Acta radiologica: therapy, physics, biology. 14, 2, s. 164-176 13 s.

Histological and histochemical studies on combined heat-Roentgen treatment of a C3H mouse mammary carcinoma

Overgaard, J. & Heyden, G., 1974, I : Histochemistry. 42, 1, s. 47-59 13 s.

Investigation on the possibility of a thermic tumour therapy. II. Action of combined heat-roentgen treatment on a transplanted mouse mammary carcinoma

Overgaard, K. & Overgaard, J., okt. 1972, I : European Journal of Cancer. 8, 5, s. 573-5 3 s.

Investigations on the possibility of a thermic tumour therapy. I. Short-wave treatment of a transplanted isologous mouse mammary carcinoma

Overgaard, K. & Overgaard, J., feb. 1972, I : European Journal of Cancer. 8, 1, s. 65-78 14 s.

Aktiviteter

12th International Congress on Ocular Oncology

Jens Overgaard (Deltager)

3 sep. 20055 sep. 2005

12th International Retinoblastoma Symposium

Jens Overgaard (Deltager)

1 sep. 20053 sep. 2005

20th Meeting on Clinical and Experimental Research in Radiation Oncology (CERRO)

Jens Overgaard (Deltager)

22 jan. 200529 jan. 2005

3rd UK Radiation Oncology Conference

Jens Overgaard (Deltager)

11 apr. 200513 apr. 2005

9th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology

Jens Overgaard (Deltager)

18 jun. 200520 jun. 2005

Acta Oncologica (Tidsskrift)

Jens Overgaard (Redaktør)

1 jan. 1987 → …

Annual Conference of the Egyptian Cancer Society

Jens Overgaard (Deltager)

10 feb. 2005 → …

Clinical Breast Cancer (Tidsskrift)

Jens Overgaard (Redaktør)

1 jan. 2000 → …

Dansk Selskab for Cancerforsknings 18. årsmøde

Jens Overgaard (Deltager)

4 maj 2005 → …

ECCO 13 - the European Cancer Conference

Jens Overgaard (Deltager)

30 okt. 20053 nov. 2005

ESTRO International Symposium, TATA Memorial Hospital

Jens Overgaard (Deltager)

26 feb. 20053 mar. 2005

European Journal of Cancer (Tidsskrift)

Jens Overgaard (Redaktør)

1 jan. 1990 → …

Focus on Anaemia in Cancer (Tidsskrift)

Jens Overgaard (Redaktør)

1 mar. 200131 dec. 2004

HIF-1 upregulated genes as endogenous markers for tumour hypoxia

Jens Overgaard (Oplægsholder)

4 maj 2005

Importance of HER2 and receptor status on the response to adjuvant radiotherapy in hgih-risk breast cancer: Results from the DBCG82 b&c randomized study.

Jens Overgaard (Oplægsholder)

2006

Influence of oxygen concentration and pH on expression of hypoxia induced genes

Jens Overgaard (Oplægsholder)

18 jun. 200520 jun. 2005

International Journal of Hyperthermia (Tidsskrift)

Jens Overgaard (Redaktør)

1 jan. 198531 dec. 2003

International Journal of Radiation: Oncology - Biology - Physics (Tidsskrift)

Jens Overgaard (Redaktør)

1 jan. 1988 → …

Journal of Cancer Research and Therapeutics (Tidsskrift)

Jens Overgaard (Redaktør)

1 jan. 2005 → …

Journal of Clinical Oncology (Tidsskrift)

Jens Overgaard (Redaktør)

1 jan. 2004 → …

Journal of Experimental Therapeutics and Oncology (Tidsskrift)

Jens Overgaard (Redaktør)

1 jan. 1996 → …

Lancet Oncology (Tidsskrift)

Jens Overgaard (Redaktør)

10 mar. 2000 → …

Nordic Society for Gynecological Oncology Symposium

Jens Overgaard (Deltager)

9 sep. 2005 → …

Nowotwory (Polish Oncological Journal) (Tidsskrift)

Jens Overgaard (Redaktør)

12 mar. 2001 → …

Oxygen dependent expression of endogenous hypoxia markers and the influence of pH

Jens Overgaard (Oplægsholder)

20 aug. 200523 aug. 2005

Prognostic and predictive importance of CA IX in high-risk breast cancer.: Results from the DBCG82 b&c randomized study.

Jens Overgaard (Oplægsholder)

2006

Radiotherapy & Oncology (Tidsskrift)

Jens Overgaard (Redaktør)

1 jan. 1983 → …

Reproductive death of cancer cells induced by femtosecond laser pulses

Jens Overgaard (Oplægsholder)

17 jun. 200622 jun. 2006

SSHNO 2005 - 17th Annual Meeting of the Scandinavian Society for Head and Neck Oncology

Jens Overgaard (Deltager)

22 apr. 200524 apr. 2005

Seminars in Radiation Oncology (Tidsskrift)

Jens Overgaard (Redaktør)

24 sep. 1990 → …

Sydsvenska Onkologiska Sällskapet

Jens Overgaard (Deltager)

30 maj 2005 → …

The Good, the Bad, and the Ugly. Prognostic subgroups predictive of response to post-mastectomy radiotherapy in high-risk breast cancer.: Results from the DBCG82 b&c randomized stydy.

Jens Overgaard (Oplægsholder)

2006

The genetic basis of normal tissue reactions after radiotherapy

Jens Overgaard (Oplægsholder)

3 jul. 20057 jul. 2005

Third International Symposium on the Molecular Biology of Breast Cancer

Jens Overgaard (Deltager)

24 jun. 200526 jun. 2005

WP5 - tumour hypoxia and microenvironment

Jens Overgaard (Oplægsholder)

12 okt. 200513 okt. 2005

Årsmøde i Dansk Selskab for Hoved- og Halsonkologi

Jens Overgaard (Deltager)

11 mar. 2005 → …

Årsmøde i Dansk Selskab for Patologisk Anatomi og Cytologi

Jens Overgaard (Deltager)

26 okt. 2005 → …